Luminar (LAZR) 10-Q 8 Aug 22 2022 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2022	Jul. 29, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	001-38791
Entity Registrant Name	Luminar Technologies, Inc./DE
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-1804317
Entity Address, Address Line One	2603 Discovery Drive
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32826
City Area Code	407
Local Phone Number	900-5259
Title of 12(b) Security	Class A common stock, par value of $0.0001 per share
Trading Symbol	LAZR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001758057
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		260,793,186
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		97,088,670

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 76,717	$ 329,977
Restricted cash	980	725
Marketable securities (including $4,721 and $12,200 with a related party as of June 30, 2022 and December 31, 2021, respectively, see Note 16)	528,548	462,141
Accounts receivable	9,279	13,013
Inventory	9,349	10,342
Prepaid expenses and other current assets	46,178	29,195
Total current assets	671,051	845,393
Property and equipment, net	19,946	11,009
Operating lease right-of-use assets	17,447	9,145
Intangible assets, net	23,458	2,424
Goodwill	18,465	3,110
Other non-current assets	25,230	12,455
Total assets	775,597	883,536
Current liabilities:
Accounts payable	20,119	14,419
Accrued and other current liabilities	31,504	19,844
Operating lease liabilities	6,217	4,735
Total current liabilities	57,840	38,998
Warrant liabilities	4,351	31,230
Convertible senior notes	610,575	608,957
Operating lease liabilities, non-current	12,464	5,768
Other non-current liabilities	1,806	598
Total liabilities	687,036	685,551
Commitments and contingencies (Note 14)
Stockholders’ equity:
Additional paid-in capital	1,413,064	1,257,214
Accumulated other comprehensive loss	(6,005)	(908)
Treasury stock	(312,477)	(235,871)
Accumulated deficit	(1,006,059)	(822,487)
Total stockholders’ equity	88,561	197,985
Total liabilities and stockholders’ equity	775,597	883,536
Class A Common Stock
Stockholders’ equity:
Common stock	28	27
Class B Common Stock
Stockholders’ equity:
Common stock	$ 10	$ 10

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Marketable securities	$ 528,548	$ 462,141
Related party
Marketable securities	$ 4,721	$ 12,200

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Total revenue	$ 9,932	$ 6,309	$ 16,787	$ 11,622
Total cost of sales	28,092	7,853	44,746	15,492
Gross loss	(18,160)	(1,544)	(27,959)	(3,870)
Operating expenses:
Research and development	40,941	19,913	74,050	33,923
Sales and marketing	7,189	3,507	16,587	6,142
General and administrative	38,150	19,237	68,175	29,510
Total operating expenses	86,280	42,657	158,812	69,575
Loss from operations	(104,440)	(44,201)	(186,771)	(73,445)
Change in fair value of warrant liabilities	11,733	6,928	7,876	(39,721)
Interest expense and other	(3,148)	(288)	(6,428)	(488)
Interest income and other	603	731	2,142	901
Total other income (expense), net	9,188	7,371	3,590	(39,308)
Loss before provision for (benefit from) income taxes	(95,252)	(36,830)	(183,181)	(112,753)
Provision for (benefit from) income taxes	(13)	0	391	0
Net loss	$ (95,239)	$ (36,830)	$ (183,572)	$ (112,753)
Net loss per share:
Basic (in dollars per share)	$ (0.27)	$ (0.11)	$ (0.52)	$ (0.33)
Diluted (in dollars per share)	$ (0.27)	$ (0.11)	$ (0.52)	$ (0.33)
Shares used in computing net loss per share:
Basic (in shares)	352,054,529	340,255,023	350,378,494	336,641,349
Diluted (in shares)	352,054,529	340,255,023	350,378,494	336,641,349
Comprehensive Loss:
Net loss	$ (95,239)	$ (36,830)	$ (183,572)	$ (112,753)
Net unrealized losses on available-for-sale debt securities	(1,449)	16	(5,097)	(27)
Comprehensive loss	(96,688)	(36,814)	(188,669)	(112,780)
Products
Total revenue	1,798	1,977	3,339	4,910
Total cost of sales	16,987	3,720	28,805	9,029
Services
Total revenue	8,134	4,332	13,448	6,712
Total cost of sales	$ 11,105	$ 4,133	$ 15,941	$ 6,463

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Freedom Photonics	Solfice	Additional Paid-in Capital	Additional Paid-in Capital Freedom Photonics	Additional Paid-in Capital Solfice	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Accumulated Deficit	Class A Common Stock	Class A Common Stock Common Stock	Class A Common Stock Common Stock Freedom Photonics	Class A Common Stock Common Stock Solfice	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2020											218,818,037				105,118,203
Beginning balance at Dec. 31, 2020	$ 148,741			$ 733,175			$ 34	$ 0	$ (584,501)		$ 22				$ 11
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of warrants (in shares)											15,574,037
Issuance of Class A common stock upon exercise of warrants	492,221			492,219							$ 2
Issuance of Class A common stock upon exercise of stock options (in shares)											2,091,613
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	3,206			3,206
Share-based compensation	15,758			15,758
Payments of employee taxes related to stock-based awards	(140)			(140)
Cash received from Gores on settlement of recapitalization of escrow	10			10
Other comprehensive income (loss)	(27)						(27)
Net loss	(112,753)								(112,753)
Ending balance (in shares) at Jun. 30, 2021											236,483,687				105,118,203
Ending balance at Jun. 30, 2021	547,016			1,244,228			7	0	(697,254)		$ 24				$ 11
Beginning balance (in shares) at Mar. 31, 2021											234,575,992				105,118,203
Beginning balance at Mar. 31, 2021	567,160			1,227,559			(9)	0	(660,424)		$ 23				$ 11
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of warrants (in shares)											0
Issuance of Class A common stock upon exercise of warrants	0			0							$ 0
Issuance of Class A common stock upon exercise of stock options (in shares)											1,907,695
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	2,885			2,884							$ 1
Share-based compensation	13,915			13,915
Payments of employee taxes related to stock-based awards	(140)			(140)
Cash received from Gores on settlement of recapitalization of escrow	10			10
Other comprehensive income (loss)	16						16
Net loss	(36,830)								(36,830)
Ending balance (in shares) at Jun. 30, 2021											236,483,687				105,118,203
Ending balance at Jun. 30, 2021	547,016			1,244,228			7	0	(697,254)		$ 24				$ 11
Beginning balance (in shares) at Dec. 31, 2021											266,076,525				97,088,670
Beginning balance at Dec. 31, 2021	197,985			1,257,214			(908)	(235,871)	(822,487)		$ 27				$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(76,606)							(76,606)
Issuance of Class A common stock upon exercise of warrants (in shares)											405,752
Issuance of Class A common stock upon exercise of warrants	$ 19,003			19,003
Issuance of Class A common stock upon exercise of stock options (in shares)	1,053,499
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)											4,185,398
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	$ 1,744			1,744
Retirement of unvested restricted common stock (in shares)											(43,556)
Vendor payments in shares in lieu of cash (in shares)											9,036,665
Vendor stock-in-lieu of cash program	43,758			43,757							$ 1
Acquisition (in shares)												2,176,205	374,193
Acquisitions		$ 30,510	$ 3,361		$ 30,510	$ 3,361
Share-based compensation	59,199			59,199
Payments of employee taxes related to stock-based awards	(1,724)			(1,724)
Other comprehensive income (loss)	(5,097)						(5,097)
Net loss	(183,572)								(183,572)
Ending balance (in shares) at Jun. 30, 2022										260,348,203	282,211,182			97,088,670	97,088,670
Ending balance at Jun. 30, 2022	88,561			1,413,064			(6,005)	(312,477)	(1,006,059)		$ 28				$ 10
Beginning balance (in shares) at Mar. 31, 2022											269,978,536				97,088,670
Beginning balance at Mar. 31, 2022	123,884			1,314,742			(4,556)	(275,519)	(910,820)		$ 27				$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(36,958)							(36,958)
Issuance of Class A common stock upon exercise of warrants (in shares)											4,387
Issuance of Class A common stock upon exercise of warrants	314			314
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)											2,068,339
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	659			659
Retirement of unvested restricted common stock (in shares)											(2,793)
Vendor payments in shares in lieu of cash (in shares)											7,612,315
Vendor stock-in-lieu of cash program	29,145			29,144							$ 1
Acquisition (in shares)												2,176,205	374,193
Acquisitions		$ 30,510	$ 3,361		$ 30,510	$ 3,361
Share-based compensation	35,542			35,542
Payments of employee taxes related to stock-based awards	(1,208)			(1,208)
Other comprehensive income (loss)	(1,449)						(1,449)
Net loss	(95,239)								(95,239)
Ending balance (in shares) at Jun. 30, 2022										260,348,203	282,211,182			97,088,670	97,088,670
Ending balance at Jun. 30, 2022	$ 88,561			$ 1,413,064			$ (6,005)	$ (312,477)	$ (1,006,059)		$ 28				$ 10

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	$ (183,572)	$ (112,753)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,544	1,332
Noncash lease expense related to operating lease right-of-use assets	2,139	1,748
Amortization of premium on marketable securities	919	602
Change in fair value of warrants	(7,876)	39,721
Vendor stock-in-lieu of cash program	19,916	0
Amortization of debt discount and issuance costs	1,618	0
Impairment of inventories	4,778	1,453
Share-based compensation	65,323	16,367
Product warranty and other	171	572
Changes in operating assets and liabilities:
Accounts receivable	7,038	3,527
Inventories	(2,814)	(2,640)
Prepaid expenses and other current assets	(2,417)	(8,469)
Other non-current assets	(532)	(1,490)
Accounts payable	7,392	854
Accrued and other current liabilities	1,106	2,652
Other non-current liabilities	(931)	(1,659)
Net cash used in operating activities	(85,198)	(58,183)
Cash flows from investing activities:
Purchases of marketable securities	(270,440)	(376,289)
Proceeds from maturities of marketable securities	147,053	169,619
Proceeds from sales of marketable securities	50,315	36,937
Purchases of property and equipment	(7,491)	(2,710)
Advances for capital projects and equipment	(1,673)	0
Net cash used in investing activities	(86,996)	(172,443)
Cash flows from financing activities:
Proceeds from exercise of warrants	0	153,927
Proceeds from exercise of stock options	1,791	2,812
Payments of employee taxes related to stock-based awards	(1,724)	(140)
Repurchase of common stock and redemption of warrants	(80,878)	(2)
Other financing activities	0	(276)
Net cash provided by (used in) financing activities	(80,811)	156,321
Net decrease in cash, cash equivalents and restricted cash	(253,005)	(74,305)
Beginning cash, cash equivalents and restricted cash	330,702	209,719
Ending cash, cash equivalents and restricted cash	77,697	135,414
Supplemental disclosures of cash flow information:
Cash paid for interest	3,863	37
Supplemental disclosures of noncash investing and financing activities:
Issuance of Class A common stock upon exercise of warrants	19,003	338,293
Operating lease right-of-use assets obtained in exchange for lease obligations	9,993	2,876
Purchases of property and equipment recorded in accounts payable and accrued liabilities	2,630	222
Vendor stock-in-lieu of cash program—advances for capital projects and equipment	10,293	0
Receivable from stock option exercises	0	394
Freedom Photonics
Cash flows from investing activities:
Acquisitions	(2,759)	0
Solfice
Cash flows from investing activities:
Acquisitions	$ (2,001)	0
Upon adoption of ASC 842
Supplemental disclosures of noncash investing and financing activities:
Operating lease right-of-use assets obtained in exchange for lease obligations		$ 10,849

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Luminar Technologies, Inc. and its wholly-owned subsidiaries (the “Company” or “Luminar”) was originally incorporated in Delaware on August 28, 2018 under the name Gores Metropoulos, Inc (“Gores”). The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. On December 2, 2020 (the “Closing Date”), the Company (at such time named Gores Metropoulos, Inc.) consummated the business combination (the “Business Combination”) pursuant to the Agreement and Plan of Merger (the “Merger Agreement”), dated August 24, 2020 with the pre-Business Combination Luminar Technologies, Inc. (“Legacy Luminar”). Legacy Luminar was incorporated in Delaware on March 31, 2015. In connection with the consummation of the Business Combination, the Company changed its name from Gores Metropoulos, Inc. to Luminar Technologies, Inc. The Company’s common stock is listed on the NASDAQ under the symbol “LAZR.” The Company’s public warrants to purchase shares of Class A common stock were listed on the NASDAQ under the symbol “LAZRW,” until they were delisted on March 5, 2021 upon exercise and redemption. Unless the context otherwise requires, the “Company” refers to the combined company and its subsidiaries following the Business Combination, “Gores” refers to the Company prior to the Business Combination and “Legacy Luminar” refers to Luminar Technologies, Inc., prior to the Business Combination. Refer to Reverse Merger with Gores in Note 3 to the financial statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 for additional information relating to the Business Combination. The Company is a developer of advanced sensor technologies and software for the autonomous vehicle industry, encompassing Laser Imaging, Detection and Ranging (lidar) technology. The Company manufactures and distributes commercial lidar sensors and certain components for the autonomous vehicle industry. The Company is headquartered in Orlando, Florida and has various facilities located in the United States and internationally in Munich, Germany.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory reserves, valuation allowance for deferred tax assets, valuation of warrants, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates. Segment Information The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company has two business activities which are its operating segments: (i) “Autonomy Solutions” for automotive applications, which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, and development of software products that enable autonomy capabilities. In June 2022, the Company acquired assets from Solfice Research, Inc. (“Solfice”), which have been included in the Autonomy Solutions segment. (ii) “Advanced Technologies and Services (“ATS”)” which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits. In the second quarter of 2022, the Components segment was renamed as ATS. In August 2021 and in April 2022, the Company acquired Optogration, Inc. (“Optogration”) and Freedom Photonics LLC (“Freedom Photonics”), respectively, which have been included in the ATS segment. Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, marketable investments and accounts receivable. A significant portion of the Company’s cash and cash equivalents is held at high-quality domestic financial institutions. Deposits held with the financial institutions may, at times, exceed the amount of insurance provided on such deposits . Cash held by the Company in foreign entities as of June 30, 2022 and December 31, 2021 was not material. The Company’s revenue is derived from customers located in the United States and international markets. Two customers accounted for 17% and 13% of the Company’s accounts receivable at June 30, 2022. Two customers accounted for 39% and 31% of the Company’s accounts receivable at December 31, 2021. Significant Accounting Policies The Company’s significant accounting policies are disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021. There has been no material change to the Company’s significant accounting policies during the six months ended June 30, 2022, except as noted below related to revenue recognition from long-term contracts as part of Freedom Photonics acquisition. Consistent with the revenue recognition for NRE services, for Freedom Photonics long-term contracts, the Company recognizes revenue over time using an input method based on contract cost incurred to date compared to total estimated contracts (cost-to-cost). Contract costs are incurred over a period of time, which can be several years, and the estimation of these costs requires management’s judgment. The Company reviews the estimate at completion on significant contracts on a periodic basis and for others, no less than annually or when a change in circumstances warrant a modification to a previous estimate. Due to the nature of the work required to be performed on many of the Company’s performance obligations, the estimation of total revenue and cost at completion is complex, subject to many variables and requires significant judgment by management on a contract by contract basis. Changes in estimates of transaction price, revenue, cost of sales and the related impact to operating profit are recognized on a cumulative catch-up basis, which recognizes the cumulative effect of the profit changes on current and prior periods in the current period. Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. No. 2021-08 (“ASU 2021-08”), Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers . ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.

Business Combination

Business Combination	6 Months Ended
	Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combination	Business Combination Freedom Photonics Acquisition On April 13, 2022 (the “Acquisition Date”), the Company completed its acquisition of Freedom Photonics, a designer and manufacturer of high-performance lasers and related photonic products. The Freedom Photonics acquisition is expected to help the Company secure intellectual property and the supply of a key enabling component as part of the Company’s vertical integration strategy. Pursuant to the terms of the Merger Agreement between the Company and Freedom Photonics, the Company acquired all of the issued and outstanding units of capital of Freedom Photonics for an aggregate purchase price of approximately $34.2 million payable primarily in Class A common stock of the Company. In conjunction with the acquisition, the Company issued share-based compensation awards to certain employees and selling shareholders of Freedom Photonics, which may result in future stock-based compensation expense, subject to achievement of certain service and performance conditions. The results of operations related to Freedom Photonics are included in the Company’s consolidated statements of operations beginning from the Acquisition Date. As part of the transaction, the Company incurred $1.4 million of acquisition-related costs, which were expensed and included in general and administrative expenses in the periods in which the costs were incurred. Recording of Assets Acquired and Liabilities Assumed Preliminary estimates of fair values included in the consolidated financial statements are expected to be finalized within a year following the Acquisition Date. These are related to certain working capital adjustments and finalization of the estimates relating to deferred tax balances which will occur after the filing of the current tax returns. After the measurement period, any subsequent adjustments will be reflected in the consolidated statements of operations. The following table summarizes the preliminary purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments (in thousands): Preliminary Recorded Value Cash and cash equivalents $ 1,063 Accounts receivable 3,235 Contract asset 1,913 Inventories, net 127 Prepaid expenses and other current assets 70 Property and equipment 1,353 Operating lease right-of-use assets 449 Other non-current assets 22 Intangible assets (1) 15,600 Goodwill (2) 15,520 Total assets acquired 39,352 Current Liabilities (4,036) Non-current liabilities (1,135) Total liabilities assumed (5,171) Net assets acquired $ 34,181 (1) Tradename was measured using the relief-from-royalty method. The remaining identifiable intangible assets were measured using the income approach. Significant inputs used as part of the valuation of intangible assets include revenue forecasts, present value factors, expected product margins and costs to complete the IPR&D. (2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included assembled workforce and component cost savings. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the ATS segment, which is also deemed the reporting unit. Identifiable intangible assets recognized (in thousands): Useful Life Preliminary Recorded Value Customer backlog ≤ 2 years $ 650 Customer relationships 4 years 2,950 Developed technology 8 years 4,000 In-process research and development (IPR&D) (1) 7,500 Tradename 4 years 500 Total intangible assets $ 15,600 (1) IPR&D intangibles are treated as indefinite-lived until the completion or abandonment of the associated R&D project, at which time the appropriate useful lives will be determined. Supplemental Unaudited Pro Forma Information The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Freedom Photonics as if the companies were combined as of the beginning of fiscal year 2021. The unaudited pro forma information includes adjustments to amortization and depreciation for intangible assets and property and equipment acquired, the purchase accounting effect on transaction costs, and stock-based compensation costs. The table below reflects the impact of adjustments to the unaudited pro forma results for the three and six months ended June 30, 2022 and 2021 that are directly attributable to the acquisition (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited) (Decrease) / increase to expenses as a result of transaction costs $ (417) $ — $ (2,582) $ 2,795 (Decrease) / increase to expenses as a result of stock-based compensation expense 525 4,271 4,159 11,277 Nonrecurring pro forma adjustments include: • Transaction costs of $2.8 million are assumed to have occurred on January 1, 2021, and are recognized as if incurred in the first quarter of 2021; • Employee compensation in connection with the retention awards, incentive plan awards, sign-on bonuses, and deferred shares are assumed to have started on January 1, 2021, and recognized as incurred based on their respective periods. The unaudited pro forma information presented below is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2021 or the results of our future operations of the combined businesses (in thousands). Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited) Revenue $ 10,481 $ 11,385 $ 22,511 $ 21,534 Net loss (95,470) (40,823) (185,410) (126,631) Solfice Assets Acquisition

Revenue

Revenue	6 Months Ended
	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The Company’s revenue is comprised of sales of lidar sensors hardware, components and NRE services. Disaggregation of Revenues The Company disaggregates its revenue from contracts with customers by (1) geographic region based on customer’s billed to location, and (2) type of good or service and timing of transfer of goods or services to customers (point-in-time or over time), as it believes it best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands): Three Months Ended June 30, 2022 2021 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 8,716 88 % $ 4,061 65 % Asia Pacific 932 9 % 154 2 % Europe and Middle East 284 3 % 2,094 33 % Total $ 9,932 100 % $ 6,309 100 % Revenue by timing of recognition: Recognized at a point in time $ 1,798 18 % $ 1,988 32 % Recognized over time 8,134 82 % 4,321 68 % Total $ 9,932 100 % $ 6,309 100 % Revenue by segment: Autonomy Solutions $ 4,179 42 % $ 5,822 92 % ATS 5,753 58 % 487 8 % Total $ 9,932 100 % $ 6,309 100 % Six Months Ended June 30, 2022 2021 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 13,684 81 % $ 6,600 57 % Asia Pacific 2,792 17 % 475 4 % Europe and Middle East 311 2 % 4,547 39 % Total $ 16,787 100 % $ 11,622 100 % Revenue by timing of recognition: Recognized at a point in time $ 3,339 20 % $ 4,041 35 % Recognized over time 13,448 80 % 7,581 65 % Total $ 16,787 100 % $ 11,622 100 % Revenue by segment: Autonomy Solutions $ 10,077 60 % $ 10,158 87 % ATS 6,710 40 % 1,464 13 % Total $ 16,787 100 % $ 11,622 100 % Volvo Stock Purchase Warrant In March 2020, the Company issued a stock purchase warrant (“Volvo Warrants”) to Volvo Car Technology Fund AB (“VCTF”) in connection with an engineering services contract. The Volvo Warrants entitle VCTF to purchase up to 4,089,280 shares of Class A common stock, at a price of $3.1769 per share from the Company and were determined to be an equity classified award to VCTF. The Volvo Warrants vest and become exercisable in two tranches based on satisfaction of certain commercial milestones, upon reaching commercial production and delivering of production units. The grant date fair value of warrants, aggregating $2.9 million, represents consideration payable to VCTF and will be recognized as reduction in revenue consistent with the revenue recognition pattern when these warrants become probable of vesting. The Company’s management determined that the vesting of the first of the two tranches of Volvo Warrants was probable as of December 31, 2021. As such, the Company had recognized a reduction in revenue in the amount of $1.0 million related to the said first tranche of the Volvo Warrants in the year ended December 31, 2021. The second tranche will be expensed upon achievement of sales of a certain number of the Company’s sensors to Volvo for use in their commercial vehicles. This threshold had not been achieved as of the end of the second quarter of 2022. Contract assets and liabilities Contract assets primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. The Company’s contract assets as of June 30, 2022 and December 31, 2021 were $18.3 million and $9.9 million, respectively. Contract liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized related to product sales and other services revenue and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent required customer payments in advance of product shipments according to customer’s payment term. Customer advance payments are recognized in revenue as or when control of the performance obligation is transferred to the customer. The Company’s contract liabilities were $3.7 million and $0.9 million as of June 30, 2022 and December 31, 2021, and were included in accrued and other current liabilities in the condensed consolidated balance sheets. The significant changes in contract assets balances consisted of the following (in thousands): June 30, 2022 December 31, 2021 Beginning balance $ 9,907 $ — Amounts billed that were included in the contract assets beginning balance (1,602) Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 9,992 9,907 Ending balance $ 18,297 $ 9,907 The opening and closing balances of contract liabilities were as follows (in thousands): June 30, 2022 December 31, 2021 Contract liabilities, current $ 3,665 $ 898 Contract liabilities, non-current 33 — Ending balance $ 3,698 $ 898 The significant changes in contract liabilities balances consisted of the following (in thousands): June 30, 2022 December 31, 2021 Beginning balance $ 898 $ 2,284 Revenue recognized that was included in the contract liabilities beginning balance (397) (1,792) Net increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 3,197 406 Ending balance $ 3,698 $ 898

Investments

Investments	6 Months Ended
	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Debt Securities The Company’s investments in debt securities consisted of the following as of June 30, 2022 and December 31, 2021 (in thousands): June 30, 2022 Cost Gross Gross Fair Value U.S. treasury securities $ 241,313 $ — $ (3,556) $ 237,757 U.S. agency and government sponsored securities 4,997 — (116) 4,881 Commercial paper 82,168 — (156) 82,012 Corporate bonds 147,720 — (1,838) 145,882 Asset-backed securities 31,734 — (339) 31,395 Total debt securities $ 507,932 $ — $ (6,005) $ 501,927 Included in cash and cash equivalents $ 7,499 $ — $ (1) $ 7,498 Included in marketable securities 500,433 — (6,004) 494,429 December 31, 2021 Cost Gross Gross Fair Value U.S. treasury securities $ 161,938 $ 1 $ (474) $ 161,465 U.S. agency and government sponsored securities 4,995 — (25) 4,970 Commercial paper 40,788 — (4) 40,784 Corporate bonds 165,522 13 (345) 165,190 Asset-backed securities 46,540 — (74) 46,466 Total debt securities $ 419,783 $ 14 $ (922) $ 418,875 Included in cash and cash equivalents $ 950 $ — $ — $ 950 Included in marketable securities 418,833 14 (922) 417,925 The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of June 30, 2022 and December 31, 2021 (in thousands): June 30, 2022 December 31, 2021 Gross Fair Value Gross Fair Value U.S. treasury securities $ (3,556) $ 237,757 $ (474) $ 146,454 U.S. agency and government sponsored securities (116) 4,881 (25) 4,970 Commercial paper (156) 82,012 (4) 30,285 Corporate bonds (1,838) 145,882 (345) 145,522 Asset-backed securities (339) 31,395 (74) 45,251 Total $ (6,005) $ 501,927 $ (922) $ 372,482 Equity Investments The Company’s equity investments consisted of the following as of June 30, 2022 and December 31, 2021 (in thousands): Condensed Consolidated Balance Sheets Location June 30, 2022 December 31, 2021 Money market funds (1) Cash and cash equivalents $ 28,107 $ 25,654 Marketable equity investments (1) Marketable securities 34,119 $ 44,216 Non-marketable equity investment measured using the measurement alternative (2) Other non-current assets $ 10,002 $ 10,002 Total $ 72,228 $ 79,872 (1) Investments with readily determinable fair values. (2) Investment in privately held company without readily determinable fair value. In December 2021, the Company made an investment in 1,495 Class A Preferred Units of Robotic Research OpCo, LLC (“Robotic Research”) for consideration of $10.0 million, which was settled by issuing 618,924 shares of Class A common stock of the Company. The Company’s investment in Robotic Research represents less than 5% of Robotic Research’s capitalization. The Company neither has a significant influence over Robotic Research nor does its investment amount to a controlling financial interest in Robotic Research. As such, the Company measured the investment in Robotic Research at cost as provided under the guidance for measurement of equity investment using the measurement alternative. Total realized and unrealized gains and losses associated with the Company’s marketable equity investments were not material in the three and six months ended June 30, 2022 and 2021.

Financial Statement Components

Financial Statement Components	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Financial Statement Components	Financial Statement Components Cash and Cash Equivalents Cash and cash equivalents consisted of the following (in thousands): June 30, 2022 December 31, 2021 Cash $ 41,112 $ 303,373 Money market funds 28,107 25,654 Commercial paper 7,498 950 Total cash and cash equivalents $ 76,717 $ 329,977 Inventories, net Inventories consisted of the following (in thousands): June 30, 2022 December 31, 2021 Raw materials $ 2,900 $ 5,866 Work-in-process 6,181 1,171 Finished goods 268 3,305 Total inventories, net $ 9,349 $ 10,342 The Company’s inventory write-down (primarily due to obsolescence, lower of cost or market assessment, and other adjustments) was $3.4 million and $4.8 million for the three and six months ended June 30, 2022, respectively and $1.2 million and $1.5 million for the three and six months ended June 30, 2021, respectively. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): June 30, 2022 December 31, 2021 Prepaid expenses $ 13,692 $ 14,651 Contract assets 18,297 9,907 Advance payments to vendors 11,188 1,810 Other receivables 3,001 2,827 Total prepaid expenses and other current assets $ 46,178 $ 29,195 Property and Equipment Property and equipment consisted of the following (in thousands): June 30, 2022 December 31, 2021 Machinery and equipment $ 10,000 $ 7,694 Computer hardware and software 2,515 2,854 Leasehold improvements 885 869 Vehicles, including demonstration fleet 2,473 2,421 Furniture and fixtures 850 272 Construction in progress 11,124 3,677 Total property and equipment 27,847 17,787 Accumulated depreciation and amortization (7,901) (6,778) Total property and equipment, net $ 19,946 $ 11,009 Property and equipment capitalized under finance lease (capital lease prior to adoption of ASC 842) were not material. Construction in progress increased due to increased capital expenditure related to tooling and other capital projects to enable us to achieve series production readiness. Depreciation and amortization expense associated with property and equipment was $0.9 million and $1.7 million for the three and six months ended June 30, 2022, respectively, and $0.7 million and $1.3 million for the three and six months ended June 30, 2021, respectively. Intangible Assets The following table summarizes the activity in the Company’s intangible assets (in thousands): June 30, 2022 December 31, 2021 Beginning of the period $ 2,424 $ — Additions 21,890 2,650 Amortization (856) (226) End of the period $ 23,458 $ 2,424 The components of intangible assets were as follows (in thousands): June 30, 2022 December 31, 2021 Gross Accumulated Net Weighted Average Gross Accumulated Net Weighted Customer relationships $ 3,730 $ (256) $ 3,474 4.4 $ 780 $ (33) $ 747 9.6 Customer backlog 650 (98) 552 1.4 — — — — Tradename 620 (151) 469 3.8 120 (120) — — Assembled workforce 130 (130) — — — — — — Developed technology 11,910 (447) 11,463 8.0 1,750 (73) 1,677 9.6 IPR&D 7,500 — 7,500 — — — — — Total intangible assets $ 24,540 $ (1,082) $ 23,458 7.0 $ 2,650 $ (226) $ 2,424 9.6 Amortization expense related to intangible assets was $0.8 million and $0.9 million for the three and six months ended June 30, 2022. There was no amortization expense related to intangible assets for the three and six months ended June 30, 2021. As of June 30, 2022, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future 2022 (remaining six months) $ 1,381 2023 2,730 2024 2,373 2025 2,373 2026 1,726 Thereafter 5,375 IPR&D 7,500 Total $ 23,458 Goodwill The following table outlines changes to the carrying amount of goodwill by the Company’s reportable segments (in thousands): Autonomy Solutions ATS Total Balance as of December 31, 2021 $ 687 $ 2,423 $ 3,110 Adjustment to goodwill related to Optogration acquisition in 2021 — (165) (165) Acquired goodwill related to Freedom Photonics in 2022 — 15,520 15,520 Balance as of June 30, 2022 $ 687 $ 17,778 $ 18,465 Other Non-Current Assets Other non-current assets consisted of the following (in thousands): June 30, 2022 December 31, 2021 Security deposits $ 2,333 $ 1,187 Non-marketable equity investment 10,002 10,002 Advance payment for capital projects 11,966 — Other non-current assets 929 1,266 Total other non-current assets $ 25,230 $ 12,455 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following (in thousands): June 30, 2022 December 31, 2021 Accrued compensation and benefits $ 16,180 $ 9,899 Accrued expenses 7,267 6,727 Warranty reserves 549 1,798 Contract liabilities 3,665 898 Accrued interest payable 327 316 Contract losses 3,492 115 Other 24 91 Total accrued and other current liabilities $ 31,504 $ 19,844

Convertible Senior Notes and Ca

Convertible Senior Notes and Capped Call Transactions	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Convertible Senior Notes and Capped Call Transactions	Convertible Senior Notes and Capped Call Transactions In December 2021, the Company issued $625.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2026 in a private placement, which included $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the option granted to the initial purchasers to purchase additional notes (collectively, the “Convertible Senior Notes”). The interest on the Convertible Senior Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2022. The Convertible Notes will mature on December 15, 2026, unless earlier repurchased or redeemed by the Company or converted pursuant to their terms. The total net proceeds from the debt offering, after deducting fees paid to the initial purchasers paid by the Company was approximately $609.4 million. Each $1,000 principal amount of the Convertible Senior Notes is initially convertible into 50.0475 shares of the Company’s Class A common stock, par value $0.0001, which is equivalent to an initial conversion price of approximately $19.98 per share. The conversion rate is subject to adjustment upon the occurrence of certain specified events prior to the maturity date but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if the Company delivers a notice of redemption in respect of some or all of the Convertible Senior Notes, the Company will, under certain circumstances, increase the conversion rate of the Convertible Senior Notes for a holder who elects to convert its Convertible Senior Notes in connection with such a corporate event or convert its Convertible Senior Notes called for redemption during the related redemption period, as the case may be. The Convertible Senior Notes are redeemable, in whole or in part (subject to certain limitations), at the Company’s option at any time, and from time to time, on or after December 20, 2024, and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, but only if certain liquidity conditions are satisfied and the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice, and (2) the trading day immediately before the date the Company sends such notice. If the Company undergoes a fundamental change (as defined in the indenture governing the Convertible Senior Notes) prior to the maturity date, holders may require the Company to repurchase for cash all or any portion of their Convertible Senior Notes in principal amounts of $1,000 or a multiple thereof at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. Holders of the Convertible Senior Notes may convert their Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding December 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March 31, 2022, if the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Class A common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of specified corporate events or distributions on the Class A common stock; and (4) if the Notes are called for redemption. On or after June 15, 2026, holders may convert all or any portion of their Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its Class A common stock or a combination of cash and shares of its Class A common stock, at the Company’s election. As of June 30, 2022, the conditions allowing holders of the Convertible Senior Notes to convert were not met. It is the Company’s current intent to settle the principal amount of its outstanding Convertible Senior Notes in cash and any excess in shares of the Company’s Class A common stock. The Convertible Senior Notes are senior unsecured obligations and will rank equal in right of payment with the Company’s future senior unsecured indebtedness; senior in right of payment to the Company’s future indebtedness that is expressly subordinated to the Convertible Senior Notes; effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries. The Company has classified the Convertible Senior Notes as a non-current liability under the guidance in ASC 470-20, as amended by ASU 2020-06. Debt discount and issuance costs aggregating approximately $16.2 million were initially recorded as a reduction to the principal amount of the Convertible Senior Notes and is being amortized as interest expense on a straight line basis over the contractual terms of the notes. The Company estimates that the difference between amortizing the debt discounts and the issuance costs using the straight line method as compared to using effective interest rate method is immaterial. The net carrying amount of the Convertible Senior Notes was as follows (in thousands): June 30, 2022 December 31, 2021 Principal $ 625,000 $ 625,000 Unamortized debt discount and issuance costs (14,425) (16,043) Net carrying amount $ 610,575 $ 608,957 The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands): Three Months Six Months Contractual interest expense $ 1,948 $ 3,874 Amortization of debt discount and issuance costs 809 1,618 Total interest expense $ 2,757 $ 5,492 The remaining term over which the debt discount and issuance costs will be amortized is 4.47 years. Interest expense of $1.9 million and $3.9 million is reflected as a component of interest (expense) income, net in the accompanying condensed consolidated statement of operations for the three and six months ended June 30, 2022. In connection with the offering of the Convertible Senior Notes, the Company entered into privately negotiated capped call option transactions with certain counterparties (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $19.98 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Convertible Senior Notes. The Capped Calls have initial cap prices of $30.16 per share, subject to certain adjustment events. The Capped Calls are generally intended to reduce the potential dilution to the Class A common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Convertible Senior Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. The Capped Calls expire on April 6, 2027, subject to earlier exercise. The Capped Calls are subject to either adjustment or termination upon the occurrence of specified extraordinary events affecting the Company, including a merger event, a tender offer, and a nationalization, insolvency or delisting involving the Company. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including changes in law, failure to deliver, and hedging disruptions. The Capped Calls are recorded in stockholders’ equity and are not accounted for as derivatives. The net cost of $73.4 million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in the accompanying consolidated balance sheet.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements As of June 30, 2022, the Company carried cash equivalents, marketable investments and Private Warrants. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded. Given that the transfer of Private Warrants to anyone outside of a small group of individuals constituting the sponsors of Gores Metropoulos, Inc. would result in the Private Warrants having substantially the same terms as the Public Warrants, management determined that the fair value of each Private Warrant is the same as that of a Public Warrant, with an insignificant adjustment for short-term marketability restrictions, as of December 31, 2021. As of June 30, 2022, management determined the fair value of the Private Warrants using observable inputs in the Black-Scholes valuation model, which used the remaining term of warrants of 3.43 years, volatility of 84.2% and a risk-free rate of 2.99%. Accordingly, the Private Warrants are classified as Level 3 financial instruments. The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands): Private Warrants Balance as of December 31, 2021 $ 31,230 Change in fair value prior to exercises 4,713 Reduction in liability due to exercises (19,003) Change in fair value of outstanding warrants (12,589) Balance as of June 30, 2022 $ 4,351 The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): Fair Value (in thousands) Measured as of Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 28,107 $ — $ — $ 28,107 Commercial paper — 7,498 — 7,498 Total cash equivalents $ 28,107 $ 7,498 $ — $ 35,605 Marketable investments: U.S. treasury securities $ 237,757 $ — $ — $ 237,757 U.S. agency and government sponsored securities — 4,881 — 4,881 Commercial paper — 74,514 — 74,514 Corporate bonds — 145,882 — 145,882 Asset-backed securities — 31,395 — 31,395 Equity investments 34,119 — — 34,119 Total marketable investments $ 271,876 $ 256,672 $ — $ 528,548 Liabilities: Private Warrants $ — $ — $ 4,351 $ 4,351 Total warrant liabilities $ — $ — $ 4,351 $ 4,351 Fair Value (in thousands) Measured as of Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 25,654 $ — $ — $ 25,654 Commercial paper — 950 — 950 Total cash equivalents $ 25,654 $ 950 $ — $ 26,604 Marketable investments: U.S. treasury securities $ 161,465 $ — $ — $ 161,465 U.S. agency and government sponsored securities — 4,970 — 4,970 Commercial paper — 39,834 — 39,834 Corporate bonds — 165,190 — 165,190 Asset-backed securities — 46,466 — 46,466 Marketable equity investments 44,216 — — 44,216 Total marketable investments $ 205,681 $ 256,460 $ — $ 462,141 Liabilities: Private Warrants — — 31,230 31,230 Total warrant liabilities $ — $ — $ 31,230 $ 31,230 As of June 30, 2022 and December 31, 2021, the estimated fair value of the Company’s outstanding Convertible Senior Notes was $353.8 million and $669.4 million, respectively. The fair value was determined based on the quoted price of the Convertible Senior Notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 7 for further information on the Company’s Convertible Senior Notes. The Company’s other financial instruments’ fair value, including accounts receivable, accounts payable and other current liabilities, approximate its carrying value due to the relatively short maturity of those instruments. The carrying amounts of the Company’s finance leases approximate their fair value, which is the present value of expected future cash payments based on assumptions about current interest rates and the creditworthiness of the Company.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Earnings (Loss) Per Share Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock during the period plus, common stock equivalents, as calculated under the treasury stock method, outstanding during the period. If the Company reports a net loss, the computation of diluted loss per share excludes the effect of dilutive common stock equivalents, as their effect would be antidilutive. The Company computes earnings (loss) per share using the two-class method for its Class A and Class B common stock. Earnings (loss) per share is same for both Class A and Class B common stock since they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per share for the three and six months ended June 30, 2022 and 2021 (in thousands, except for share and per share amounts): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Numerator: Net loss $ (95,239) $ (36,830) $ (183,572) $ (112,753) Denominator: Weighted average common shares outstanding—Basic 352,054,529 340,255,023 350,378,494 336,641,349 Weighted average common shares outstanding—Diluted 352,054,529 340,255,023 350,378,494 336,641,349 Net loss per share attributable to common shareholders—Basic and Diluted $ (0.27) $ (0.11) $ (0.52) $ (0.33) The following table presents the potential shares of Common Stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: June 30, 2022 Warrants 5,757,549 Stock-based awards—Equity classified 41,876,648 Stock-based awards—Liability classified 12,563,535 Vendor stock-in-lieu of cash program 969,224 Convertible Senior Notes 31,279,716 Earn-out shares 8,606,717 Total 101,053,389

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Class A and Class B Common Stock The Company’s Board of Directors has authorized two classes of common stock, Class A and Class B. As of June 30, 2022, the Company had authorized 715,000,000 and 121,000,000 shares of Class A and Class B common stock with a par value of $0.0001 per share for each class. As of June 30, 2022, the Company had 282,211,653 shares issued and 260,348,203 shares outstanding of Class A common stock, and 97,088,670 shares issued and outstanding of Class B common stock. Holders of the Class A and Class B common stock have identical rights, except that holders of the Class A common stock are entitled to one vote per share and the holder of the Class B common stock is entitled to ten votes per share. Public and Private Warrants As of December 31, 2021, the Company had no Public Warrants and 3,077,021 Private Warrants outstanding. In January 2022 and April 2022, 1,389,529 and 19,223 Private Warrants were exercised on a cashless basis and the Company issued 401,365 and 4,387 shares of Class A common stock pursuant to the exercises. The Company had 1,668,269 Private Warrants outstanding as of June 30, 2022. These Private Warrants are set to expire on December 2, 2025. Each Private Warrant allows the holder to purchase one share of Class A common stock at $11.50 per share. Stock-in-lieu of Cash Program The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors / third parties for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). During the three and six months ended June 30, 2022, the Company issued 7,612,315 and 8,286,665 shares of Class A common stock as part of the Stock-in-lieu of Cash Program. The Company considers the shares issuable under the Stock-in-lieu of Cash Program as liability classified awards when the arrangement with the vendors requires the Company to issue a variable number of shares to settle amounts owed. As of June 30, 2022, the Company had a total of $27.6 million in prepaid expenses and other current and non-current assets related to its Stock-in-lieu of Cash Program. In November 2021, the Company entered into an agreement with Daimler North America Corporation (“Daimler”) wherein Daimler will be providing certain data and other services. To compensate Daimler for these services, the Company agreed to issue 1.5 million shares of Class A common stock to Daimler. These shares vest over a period of two years. The Company recorded costs related to these shares as research and development expense of $1.9 million and $3.9 million during the three and six months ended June 30, 2022. During the six months ended June 30, 2022, the Company issued 750,000 shares of Class A common stock related to this arrangement. The unamortized cost relating to the shares issued to Daimler under this agreement was recorded as $7.2 million in prepaid expenses and other current assets as of June 30, 2022. The Company’s vendor Stock-in-lieu of Cash Program activity for the six months ended June 30, 2022 was as follows: Shares Weighted Average Unvested shares as of December 31, 2021 1,500,000 $ 15.72 Granted 8,286,665 10.05 Vested (4,926,990) 11.06 Unvested shares as of June 30, 2022 4,859,675 10.60

Stock-based Compensation

Stock-based Compensation	6 Months Ended
	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation Prior to becoming a publicly traded entity, the Company issued incentive stock options, non-qualified stock options, and restricted stock to employees and non-employee consultants under its 2015 Stock Plan (the “2015 Plan”). Since the closing of the Business Combination, the Company has not issued any new stock-based awards under the 2015 Plan. In December 2020, the Company’s Board adopted and the Company’s stockholders approved the 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan became effective upon the closing of the Business Combination. Under the 2020 Plan, the Company was originally authorized to issue a maximum number of 36,588,278 shares of Class A common stock. In June 2022, the Company’s stockholders approved an amendment and restatement of the Company’s 2020 Plan (the “Amended 2020 Plan”) to increase the number of shares of Class A common stock authorized for issuance by 36,000,000 additional shares and added an evergreen provision under which the number of shares of Class A common stock available for issuance under the Amended 2020 Plan will be increased on the first day of each fiscal year of the Company beginning with the 2023 fiscal year and ending on (and including) the first day of the 2030 fiscal year, in an amount equal to the lesser of (i) 5% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, (ii) 40,000,000 shares or (iii) such number of shares determined by the Board. Stock Options Under the terms of the 2015 Plan, incentive stock options had an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options were permitted to be granted below fair market value of the stock on the date of grant. Stock options granted have service-based vesting conditions only. The service-based vesting conditions vary, though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a 10-year period to exercise their options before they expire. Forfeitures are recognized in the period of occurrence. A summary of the Company’s stock option activity for the six months ended June 30, 2022 was as follows: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2021 11,507,643 $ 1.72 Exercised (1,053,499) 1.67 Cancelled/Forfeited (826,089) 1.67 Outstanding as of June 30, 2022 9,628,055 1.73 7.23 $ 41,035 The aggregate intrinsic value of stock options exercised during the six months ended June 30, 2022 was $11.8 million. The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the exercise date. The total grant-date fair value of the options vested was $1.5 million during the six months ended June 30, 2022. Restricted Stock Awards Prior to June 30, 2019, the Company granted restricted stock awards to employees. Recipients purchased the restricted stock on the grant date and the Company has the right to repurchase the restricted shares at the same price recipients paid to obtain those shares. The restrictions lapse solely based on continued service, and generally lapse over 4 years —25% on the first anniversary of the date of issuance, and the remaining 75% monthly over the remaining 36 months. At the grant date of the award, recipients of restricted stock are granted voting rights and receive dividends on unvested shares. No restricted stock awards have been granted after June 30, 2019. Restricted stock awards activity for the six months ended June 30, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 666,298 $ 1.21 Forfeited (17,429) 1.23 Vested (309,888) 1.18 Outstanding as of June 30, 2022 338,981 1.23 Restricted Stock units The Company has been granting restricted stock units (“RSUs”) under the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan). Each RSU granted represents a right to receive one share of the Company’s Class A common stock when the RSU vests. RSUs generally vest over a period up to six years. The fair value of RSU is equal to the fair value of the Company’s common stock on the date of grant. A summary of the Company’s restricted stock units activity for the six months ended June 30, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 11,983,032 $ 19.56 Granted 9,974,655 12.84 Forfeited (794,702) 18.14 Vested (3,276,558) 17.73 Outstanding as of June 30, 2022 17,886,427 16.20 Fixed Value Equity Awards The Company issues fixed value equity awards to certain employees as a part of their compensation package. These awards are issued as RSUs out of the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan) and are accounted for as liability classified awards under ASC 718 — Stock Compensation. Fixed value equity awards granted have service-based conditions only and vest quarterly over a period of up to four years. These awards represent a fixed dollar amount settled in a variable number of shares determined at each vesting period. Stock-based compensation expense related to these awards was $1.7 million and $3.5 million for the three and six months ended June 30, 2022, respectively, and $0.6 million and $0.6 million for the three and six months ended June 30, 2021, respectively. Employee Stock Purchase Plan In December 2020, the Company’s board of directors and stockholders adopted the 2020 Employee Stock Purchase Plan (“2020 ESPP”) under which 7,317,655 shares were authorized for issuance. The 2020 ESPP became effective on February 26, 2021. The 2020 ESPP permits eligible employees to purchase the Company’s Class A common stock through payroll deduction with up to 15% of their pre-tax earnings subject to certain Internal Revenue Code limitations. The purchase price of shares is 85% of the lower of the fair market value of the Company’s common stock on the first day of a six-month offering period, or the relevant purchase date. In addition, no participant may purchase more than 5,000 shares of common stock in each purchase period. Optogration Awards As part of the Optogration acquisition in August 2021, the Company owes up to $22.0 million of post combination compensation related to certain service and performance conditions. As of June 30, 2022, it is probable that the conditions will be met, and as a result, the Company recorded $9.2 million in stock-based compensation expense from inception to June 30, 2022. Freedom Photonics Awards As part of the Freedom Photonics acquisition in April 2022, the Company owes up to $28.3 million of post combination compensation related to certain service and performance conditions. As of June 30, 2022, it is probable that the conditions will be met, and as a result, the Company recorded $2.8 million in stock-based compensation expense through June 30, 2022. Solfice Awards The Company owes up to $0.7 million of post combination compensation related to certain service and performance conditions. As of June 30, 2022, it is probable that the conditions will be met, and as a result, the Company recorded $0.1 million in stock-based compensation expense through June 30, 2022. Chief Executive Officer Awards On May 2, 2022, the Board of Directors of the Company granted an award of 10.8 million RSUs to Austin Russell, the Company’s Chief Executive Officer. The grant date fair value per share was $12.61 per share. The Company recorded $3.5 million in in stock-based compensation expense related to this award. This award represents Mr. Russell’s total compensation from the Company, and is subject to all of the following vesting conditions: • Market condition: Upon achievement of stock price of $50 or more, $60 or more, and $70 or more. The stock price will be measured based on the volume-weighted average price per share for 90 consecutive trading days; • Service condition: Vesting over 7-years; and • Performance condition: Upon start of production of one series production program. Compensation expense Stock-based compensation expense by function was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of sales $ 6,989 $ 1,127 $ 8,775 $ 1,210 Research and development 8,714 5,663 15,816 6,425 Sales and marketing 2,741 934 5,609 1,120 General and administrative 20,181 6,806 35,123 7,612 Total $ 38,625 $ 14,530 $ 65,323 $ 16,367 Stock-based compensation expense by type of award was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Equity Classified Awards: Stock options $ 748 $ 1,235 $ 1,270 $ 1,398 RSAs 187 250 21 1,924 RSUs 32,540 12,426 54,049 12,426 ESPP 157 — 157 — Liability Classified Awards: Fixed value equity awards 1,741 619 3,521 619 Optogration awards 394 — 3,447 — Freedom Photonics awards 2,800 — 2,800 — Solfice awards 58 — 58 — Total $ 38,625 $ 14,530 $ 65,323 $ 16,367

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Provision for income taxes for the three and six months ended June 30, 2022 and 2021 was not material . The effective tax rate w as 0.2% and 0.0% for the six months ended June 30, 2022 and 2021, respectively . The effective tax rates differ significantly from the statutory tax rate of 21%, primarily due to the Company’s valuation allowance movement in each period presented.

Leases

Leases	6 Months Ended
	Jun. 30, 2022
Leases [Abstract]
Leases	Leases The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one The components of lease expenses for were as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Operating lease cost $ 1,597 $ 1,184 $ 2,713 $ 2,358 Variable lease cost 515 445 1,070 904 Total operating lease cost $ 2,112 $ 1,629 $ 3,783 $ 3,262 Supplemental cash flow information related to leases was as follows (in thousands): Six Months Ended June 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (2,857) $ (2,459) Right of use assets obtained in exchange for lease obligations: Operating leases 9,993 2,876 Supplemental balance sheet information related to leases was as follows (in thousands): June 30, 2022 December 31, 2021 Operating leases: Operating lease right-of-use assets $ 17,447 $ 9,145 Operating lease liabilities: Operating lease liabilities, current $ 6,217 $ 4,735 Operating lease liabilities, non-current 12,464 5,768 Total operating lease liabilities $ 18,681 $ 10,503 Weighted average remaining terms were as follows (in years): June 30, 2022 December 31, 2021 Weighted average remaining lease term Operating leases 4.21 2.95 Weighted average discount rates were as follows: June 30, 2022 December 31, 2021 Weighted average discount rate Operating leases 4.23 % 2.80 % Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2022 (remaining six months) $ 3,213 2023 5,758 2024 3,298 2025 3,304 2026 2,777 2027 1,903 Thereafter 799 Total lease payments 21,052 Less: imputed interest (2,371) Total leases liabilities $ 18,681
Leases	Leases The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one The components of lease expenses for were as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Operating lease cost $ 1,597 $ 1,184 $ 2,713 $ 2,358 Variable lease cost 515 445 1,070 904 Total operating lease cost $ 2,112 $ 1,629 $ 3,783 $ 3,262 Supplemental cash flow information related to leases was as follows (in thousands): Six Months Ended June 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (2,857) $ (2,459) Right of use assets obtained in exchange for lease obligations: Operating leases 9,993 2,876 Supplemental balance sheet information related to leases was as follows (in thousands): June 30, 2022 December 31, 2021 Operating leases: Operating lease right-of-use assets $ 17,447 $ 9,145 Operating lease liabilities: Operating lease liabilities, current $ 6,217 $ 4,735 Operating lease liabilities, non-current 12,464 5,768 Total operating lease liabilities $ 18,681 $ 10,503 Weighted average remaining terms were as follows (in years): June 30, 2022 December 31, 2021 Weighted average remaining lease term Operating leases 4.21 2.95 Weighted average discount rates were as follows: June 30, 2022 December 31, 2021 Weighted average discount rate Operating leases 4.23 % 2.80 % Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2022 (remaining six months) $ 3,213 2023 5,758 2024 3,298 2025 3,304 2026 2,777 2027 1,903 Thereafter 799 Total lease payments 21,052 Less: imputed interest (2,371) Total leases liabilities $ 18,681

Commitment and Contingencies

Commitment and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase and Other Obligations The Company purchases goods and services from a variety of suppliers in the ordinary course of business. Purchase obligations are defined as agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum, or variable price provisions, and the approximate timing of the transaction. The Company had purchase obligations primarily for purchases of inventory, R&D, and general and administrative activities totaling $62.3 million as of June 30, 2022, which are expected to be received within a year. In June 2021, the Company entered into an agreement with P3 USA, Inc. (“P3”) to provide engineering, and general and administrative services. Under the said agreement, the Company issued 291,940 shares of Class A common stock to P3 in the third quarter of 2021. In September 2021, the Company entered into an amendment to modify the existing agreement with P3 and among other things, extended the term of the agreement until December 2025. The Company has committed a spend of $30.0 million with P3 over the contracted term. In May 2022, the Company entered into a strategic investment agreement with ECARX Holdings Inc. (“ECARX”) to purchase 1.5 million shares of class A ordinary shares of ECARX, at a purchase price of $10.00 per share with an aggregate amount of $15.0 million, contingent upon the closing of ECARX’s merger with a special purpose acquisition company, COVA Acquisition Corp., of which Jun Hong Heng is the Chairman and Chief Executive Officer, and a principal shareholder. Mr. Heng is also a director of Luminar. The purchase of such shares can be made with cash or Luminar’s shares of Class A common stock, at the Company’s discretion. Legal Matters From time to time, the Company is involved in actions, claims, suits and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates. The Company’s current legal accrual is not deemed to be significant to the financial statements.

Segment and Customer Concentrat

Segment and Customer Concentration Information	6 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Segment and Customer Concentration Information	Segment and Customer Concentration Information Reportable segments are (i) Autonomy Solutions and (ii) ATS. These segments reflect the way the chief operating decision maker (“CODM”) evaluates the Company’s business performance and manages its operations. Each segment has distinct product offerings, customers, and market penetration. The Chief Executive Officer is the CODM of the Company. Autonomy Solutions This segment manufactures and distributes commercial lidar sensors that measure distance using laser light to generate a highly accurate 3D map for automotive mobility applications. This segment is impacted by trends in and the strength of the autonomous vehicles and associated infrastructure/technology sector. ATS This segment is in the business of development of ultra-sensitive pixel-based sensors. This segment also designs, tests and provides consulting services for non-standard integrated circuits that are essential for systems to meet the requirement of customers. This segment is impacted by trends in and the strength of automobile and aeronautics sector as well as government spending in military and defense activities. The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands): Three Months Ended June 30, 2022 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 4,179 $ 5,753 $ 9,932 $ — $ 9,932 Revenues from internal customer 5,435 504 5,939 (5,939) — Total revenue $ 9,614 $ 6,257 $ 15,871 $ (5,939) $ 9,932 Depreciation and amortization $ 976 $ 763 $ 1,739 $ — $ 1,739 Operating income (loss) (105,592) 728 (104,864) 424 (104,440) Other significant items: Segment assets 786,708 51,046 837,754 (62,157) 775,597 Inventories, net 9,022 327 9,349 — 9,349 Three Months Ended June 30, 2021 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 5,822 $ 487 $ 6,309 $ — $ 6,309 Revenues from internal customer 1,846 1,207 3,053 (3,053) — Total revenue $ 7,668 $ 1,694 $ 9,362 $ (3,053) $ 6,309 Depreciation and amortization $ 652 $ 23 $ 675 $ — $ 675 Operating income (loss) (44,169) (76) (44,245) 44 (44,201) Other significant items: Segment assets 625,386 3,483 628,869 (2,702) 626,167 Inventories, net 4,288 30 4,318 — 4,318 Six Months Ended June 30, 2022 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 10,077 $ 6,710 $ 16,787 $ — $ 16,787 Revenues from internal customer 7,796 2,660 10,456 (10,456) — Total revenue $ 17,873 $ 9,370 $ 27,243 $ (10,456) $ 16,787 Depreciation and amortization $ 1,520 $ 1,024 $ 2,544 $ — $ 2,544 Operating loss (187,769) 998 (186,771) — (186,771) Other significant items: Segment assets 786,708 51,046 837,754 (62,157) 775,597 Inventories, net 9,022 327 9,349 — 9,349 Six Months Ended June 30, 2021 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 10,158 $ 1,464 $ 11,622 $ — $ 11,622 Revenues from internal customer 3,121 2,349 5,470 (5,470) — Total revenue $ 13,279 $ 3,813 $ 17,092 $ (5,470) $ 11,622 Depreciation and amortization $ 1,290 $ 43 $ 1,333 $ (1) $ 1,332 Operating income (loss) (73,037) (313) (73,350) (95) (73,445) Other significant items: Segment assets 625,386 3,483 628,869 (2,702) 626,167 Inventories, net 4,288 30 4,318 — 4,318 (1) Represents the eliminations of all intercompany balances and transactions during the period presented. One customer accounted for 24% of the Company’s revenue for the three months ended June 30, 2022. Two customers accounted for 35% and 15% of the Company’s revenue for the six months ended June 30, 2022. Three customers accounted for 30%, 30% and 25%, respectively, of the Company’s revenue for the three months ended June 30, 2021. Three customers accounted for 21%, 37% and 18%, respectively, of the Company’s revenue for the six months ended June 30, 2021.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Equity Investments In February 2021, the Company invested $15.0 million in a special purpose acquisition company, of which Mr. Jun Hong Heng, is the Chairman and Chief Executive Officer, and a principal shareholder. Mr. Heng became a director of the Company

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory reserves, valuation allowance for deferred tax assets, valuation of warrants, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.
Segment Information	Segment Information The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company has two business activities which are its operating segments: (i) “Autonomy Solutions” for automotive applications, which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, and development of software products that enable autonomy capabilities. In June 2022, the Company acquired assets from Solfice Research, Inc. (“Solfice”), which have been included in the Autonomy Solutions segment. (ii) “Advanced Technologies and Services (“ATS”)” which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, marketable investments and accounts receivable. A significant portion of the Company’s cash and cash equivalents is held at high-quality domestic financial institutions. Deposits held with the financial institutions may, at times, exceed the amount of insurance provided on such deposits . Cash held by the Company in foreign entities as of June 30, 2022 and December 31, 2021 was not material.
Revenue Recognition	Consistent with the revenue recognition for NRE services, for Freedom Photonics long-term contracts, the Company recognizes revenue over time using an input method based on contract cost incurred to date compared to total estimated contracts (cost-to-cost). Contract costs are incurred over a period of time, which can be several years, and the estimation of these costs requires management’s judgment. The Company reviews the estimate at completion on significant contracts on a periodic basis and for others, no less than annually or when a change in circumstances warrant a modification to a previous estimate. Due to the nature of the work required to be performed on many of the Company’s performance obligations, the estimation of total revenue and cost at completion is complex, subject to many variables and requires significant judgment by management on a contract by contract basis. Changes in estimates of transaction price, revenue, cost of sales and the related impact to operating profit are recognized on a cumulative catch-up basis, which recognizes the cumulative effect of the profit changes on current and prior periods in the current period.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. No. 2021-08 (“ASU 2021-08”), Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers . ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.
Fair Value Measurements	Fair Value Measurements As of June 30, 2022, the Company carried cash equivalents, marketable investments and Private Warrants. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.

Business Combinations (Tables)

Business Combinations (Tables)	6 Months Ended
	Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	The following table summarizes the preliminary purchase price allocation to assets acquired and liabilities assumed, including identification of measurement period adjustments (in thousands): Preliminary Recorded Value Cash and cash equivalents $ 1,063 Accounts receivable 3,235 Contract asset 1,913 Inventories, net 127 Prepaid expenses and other current assets 70 Property and equipment 1,353 Operating lease right-of-use assets 449 Other non-current assets 22 Intangible assets (1) 15,600 Goodwill (2) 15,520 Total assets acquired 39,352 Current Liabilities (4,036) Non-current liabilities (1,135) Total liabilities assumed (5,171) Net assets acquired $ 34,181 (1) Tradename was measured using the relief-from-royalty method. The remaining identifiable intangible assets were measured using the income approach. Significant inputs used as part of the valuation of intangible assets include revenue forecasts, present value factors, expected product margins and costs to complete the IPR&D. (2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included assembled workforce and component cost savings. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the ATS segment, which is also deemed the reporting unit.
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Identifiable intangible assets recognized (in thousands): Useful Life Preliminary Recorded Value Customer backlog ≤ 2 years $ 650 Customer relationships 4 years 2,950 Developed technology 8 years 4,000 In-process research and development (IPR&D) (1) 7,500 Tradename 4 years 500 Total intangible assets $ 15,600 (1) IPR&D intangibles are treated as indefinite-lived until the completion or abandonment of the associated R&D project, at which time the appropriate useful lives will be determined.
Schedule of the impact of Adjustments to the Unaudited Pro Forma	The table below reflects the impact of adjustments to the unaudited pro forma results for the three and six months ended June 30, 2022 and 2021 that are directly attributable to the acquisition (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited) (Decrease) / increase to expenses as a result of transaction costs $ (417) $ — $ (2,582) $ 2,795 (Decrease) / increase to expenses as a result of stock-based compensation expense 525 4,271 4,159 11,277
Business Acquisition, Pro Forma Information	The unaudited pro forma information presented below is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2021 or the results of our future operations of the combined businesses (in thousands). Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited) Revenue $ 10,481 $ 11,385 $ 22,511 $ 21,534 Net loss (95,470) (40,823) (185,410) (126,631)

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands): Three Months Ended June 30, 2022 2021 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 8,716 88 % $ 4,061 65 % Asia Pacific 932 9 % 154 2 % Europe and Middle East 284 3 % 2,094 33 % Total $ 9,932 100 % $ 6,309 100 % Revenue by timing of recognition: Recognized at a point in time $ 1,798 18 % $ 1,988 32 % Recognized over time 8,134 82 % 4,321 68 % Total $ 9,932 100 % $ 6,309 100 % Revenue by segment: Autonomy Solutions $ 4,179 42 % $ 5,822 92 % ATS 5,753 58 % 487 8 % Total $ 9,932 100 % $ 6,309 100 % Six Months Ended June 30, 2022 2021 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 13,684 81 % $ 6,600 57 % Asia Pacific 2,792 17 % 475 4 % Europe and Middle East 311 2 % 4,547 39 % Total $ 16,787 100 % $ 11,622 100 % Revenue by timing of recognition: Recognized at a point in time $ 3,339 20 % $ 4,041 35 % Recognized over time 13,448 80 % 7,581 65 % Total $ 16,787 100 % $ 11,622 100 % Revenue by segment: Autonomy Solutions $ 10,077 60 % $ 10,158 87 % ATS 6,710 40 % 1,464 13 % Total $ 16,787 100 % $ 11,622 100 %
Schedule of Opening and Closing Balances of Contract Liabilities and Significant Changes in Contract Liabilities	The significant changes in contract assets balances consisted of the following (in thousands): June 30, 2022 December 31, 2021 Beginning balance $ 9,907 $ — Amounts billed that were included in the contract assets beginning balance (1,602) Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 9,992 9,907 Ending balance $ 18,297 $ 9,907 The opening and closing balances of contract liabilities were as follows (in thousands): June 30, 2022 December 31, 2021 Contract liabilities, current $ 3,665 $ 898 Contract liabilities, non-current 33 — Ending balance $ 3,698 $ 898 The significant changes in contract liabilities balances consisted of the following (in thousands): June 30, 2022 December 31, 2021 Beginning balance $ 898 $ 2,284 Revenue recognized that was included in the contract liabilities beginning balance (397) (1,792) Net increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 3,197 406 Ending balance $ 3,698 $ 898

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Debt Securities, Available-for-sale	The Company’s investments in debt securities consisted of the following as of June 30, 2022 and December 31, 2021 (in thousands): June 30, 2022 Cost Gross Gross Fair Value U.S. treasury securities $ 241,313 $ — $ (3,556) $ 237,757 U.S. agency and government sponsored securities 4,997 — (116) 4,881 Commercial paper 82,168 — (156) 82,012 Corporate bonds 147,720 — (1,838) 145,882 Asset-backed securities 31,734 — (339) 31,395 Total debt securities $ 507,932 $ — $ (6,005) $ 501,927 Included in cash and cash equivalents $ 7,499 $ — $ (1) $ 7,498 Included in marketable securities 500,433 — (6,004) 494,429 December 31, 2021 Cost Gross Gross Fair Value U.S. treasury securities $ 161,938 $ 1 $ (474) $ 161,465 U.S. agency and government sponsored securities 4,995 — (25) 4,970 Commercial paper 40,788 — (4) 40,784 Corporate bonds 165,522 13 (345) 165,190 Asset-backed securities 46,540 — (74) 46,466 Total debt securities $ 419,783 $ 14 $ (922) $ 418,875 Included in cash and cash equivalents $ 950 $ — $ — $ 950 Included in marketable securities 418,833 14 (922) 417,925
Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments	The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of June 30, 2022 and December 31, 2021 (in thousands): June 30, 2022 December 31, 2021 Gross Fair Value Gross Fair Value U.S. treasury securities $ (3,556) $ 237,757 $ (474) $ 146,454 U.S. agency and government sponsored securities (116) 4,881 (25) 4,970 Commercial paper (156) 82,012 (4) 30,285 Corporate bonds (1,838) 145,882 (345) 145,522 Asset-backed securities (339) 31,395 (74) 45,251 Total $ (6,005) $ 501,927 $ (922) $ 372,482
Schedule of Equity Investments Included in Marketable Securities	December 31, 2021 Cost Gross Gross Fair Value U.S. treasury securities $ 161,938 $ 1 $ (474) $ 161,465 U.S. agency and government sponsored securities 4,995 — (25) 4,970 Commercial paper 40,788 — (4) 40,784 Corporate bonds 165,522 13 (345) 165,190 Asset-backed securities 46,540 — (74) 46,466 Total debt securities $ 419,783 $ 14 $ (922) $ 418,875 Included in cash and cash equivalents $ 950 $ — $ — $ 950 Included in marketable securities 418,833 14 (922) 417,925 The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of June 30, 2022 and December 31, 2021 (in thousands): June 30, 2022 December 31, 2021 Gross Fair Value Gross Fair Value U.S. treasury securities $ (3,556) $ 237,757 $ (474) $ 146,454 U.S. agency and government sponsored securities (116) 4,881 (25) 4,970 Commercial paper (156) 82,012 (4) 30,285 Corporate bonds (1,838) 145,882 (345) 145,522 Asset-backed securities (339) 31,395 (74) 45,251 Total $ (6,005) $ 501,927 $ (922) $ 372,482 Equity Investments The Company’s equity investments consisted of the following as of June 30, 2022 and December 31, 2021 (in thousands): Condensed Consolidated Balance Sheets Location June 30, 2022 December 31, 2021 Money market funds (1) Cash and cash equivalents $ 28,107 $ 25,654 Marketable equity investments (1) Marketable securities 34,119 $ 44,216 Non-marketable equity investment measured using the measurement alternative (2) Other non-current assets $ 10,002 $ 10,002 Total $ 72,228 $ 79,872 (1) Investments with readily determinable fair values. (2) Investment in privately held company without readily determinable fair value.

Financial Statement Components

Financial Statement Components (Tables)	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	Cash and cash equivalents consisted of the following (in thousands): June 30, 2022 December 31, 2021 Cash $ 41,112 $ 303,373 Money market funds 28,107 25,654 Commercial paper 7,498 950 Total cash and cash equivalents $ 76,717 $ 329,977
Schedule of Inventories, net	Inventories consisted of the following (in thousands): June 30, 2022 December 31, 2021 Raw materials $ 2,900 $ 5,866 Work-in-process 6,181 1,171 Finished goods 268 3,305 Total inventories, net $ 9,349 $ 10,342
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): June 30, 2022 December 31, 2021 Prepaid expenses $ 13,692 $ 14,651 Contract assets 18,297 9,907 Advance payments to vendors 11,188 1,810 Other receivables 3,001 2,827 Total prepaid expenses and other current assets $ 46,178 $ 29,195
Schedule of Property and Equipment and Property and Equipment Capitalized Under Finance Lease (Capital Lease Prior to Adoption of ASC 842)	Property and equipment consisted of the following (in thousands): June 30, 2022 December 31, 2021 Machinery and equipment $ 10,000 $ 7,694 Computer hardware and software 2,515 2,854 Leasehold improvements 885 869 Vehicles, including demonstration fleet 2,473 2,421 Furniture and fixtures 850 272 Construction in progress 11,124 3,677 Total property and equipment 27,847 17,787 Accumulated depreciation and amortization (7,901) (6,778) Total property and equipment, net $ 19,946 $ 11,009 Property and equipment capitalized under finance lease (capital lease prior to adoption of ASC 842) were not material. Construction in progress increased due to increased capital expenditure related to tooling and other capital projects to enable us to achieve series production readiness.
Schedule of Finite-Lived Intangible Assets	The following table summarizes the activity in the Company’s intangible assets (in thousands): June 30, 2022 December 31, 2021 Beginning of the period $ 2,424 $ — Additions 21,890 2,650 Amortization (856) (226) End of the period $ 23,458 $ 2,424 The components of intangible assets were as follows (in thousands): June 30, 2022 December 31, 2021 Gross Accumulated Net Weighted Average Gross Accumulated Net Weighted Customer relationships $ 3,730 $ (256) $ 3,474 4.4 $ 780 $ (33) $ 747 9.6 Customer backlog 650 (98) 552 1.4 — — — — Tradename 620 (151) 469 3.8 120 (120) — — Assembled workforce 130 (130) — — — — — — Developed technology 11,910 (447) 11,463 8.0 1,750 (73) 1,677 9.6 IPR&D 7,500 — 7,500 — — — — — Total intangible assets $ 24,540 $ (1,082) $ 23,458 7.0 $ 2,650 $ (226) $ 2,424 9.6
Schedule of Future Amortization Expense	As of June 30, 2022, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future 2022 (remaining six months) $ 1,381 2023 2,730 2024 2,373 2025 2,373 2026 1,726 Thereafter 5,375 IPR&D 7,500 Total $ 23,458
Schedule of Goodwill	The following table outlines changes to the carrying amount of goodwill by the Company’s reportable segments (in thousands): Autonomy Solutions ATS Total Balance as of December 31, 2021 $ 687 $ 2,423 $ 3,110 Adjustment to goodwill related to Optogration acquisition in 2021 — (165) (165) Acquired goodwill related to Freedom Photonics in 2022 — 15,520 15,520 Balance as of June 30, 2022 $ 687 $ 17,778 $ 18,465
Schedule of Other Noncurrent Assets	Other non-current assets consisted of the following (in thousands): June 30, 2022 December 31, 2021 Security deposits $ 2,333 $ 1,187 Non-marketable equity investment 10,002 10,002 Advance payment for capital projects 11,966 — Other non-current assets 929 1,266 Total other non-current assets $ 25,230 $ 12,455
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following (in thousands): June 30, 2022 December 31, 2021 Accrued compensation and benefits $ 16,180 $ 9,899 Accrued expenses 7,267 6,727 Warranty reserves 549 1,798 Contract liabilities 3,665 898 Accrued interest payable 327 316 Contract losses 3,492 115 Other 24 91 Total accrued and other current liabilities $ 31,504 $ 19,844

Convertible Senior Notes and _2

Convertible Senior Notes and Capped Call Transactions (Tables)	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Schedule of Net Carrying Amount	The net carrying amount of the Convertible Senior Notes was as follows (in thousands): June 30, 2022 December 31, 2021 Principal $ 625,000 $ 625,000 Unamortized debt discount and issuance costs (14,425) (16,043) Net carrying amount $ 610,575 $ 608,957
Schedule of Interest Expense	The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands): Three Months Six Months Contractual interest expense $ 1,948 $ 3,874 Amortization of debt discount and issuance costs 809 1,618 Total interest expense $ 2,757 $ 5,492

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Changes in Level 3 Liabilities Measured at Fair Value	The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands): Private Warrants Balance as of December 31, 2021 $ 31,230 Change in fair value prior to exercises 4,713 Reduction in liability due to exercises (19,003) Change in fair value of outstanding warrants (12,589) Balance as of June 30, 2022 $ 4,351
Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used	The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): Fair Value (in thousands) Measured as of Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 28,107 $ — $ — $ 28,107 Commercial paper — 7,498 — 7,498 Total cash equivalents $ 28,107 $ 7,498 $ — $ 35,605 Marketable investments: U.S. treasury securities $ 237,757 $ — $ — $ 237,757 U.S. agency and government sponsored securities — 4,881 — 4,881 Commercial paper — 74,514 — 74,514 Corporate bonds — 145,882 — 145,882 Asset-backed securities — 31,395 — 31,395 Equity investments 34,119 — — 34,119 Total marketable investments $ 271,876 $ 256,672 $ — $ 528,548 Liabilities: Private Warrants $ — $ — $ 4,351 $ 4,351 Total warrant liabilities $ — $ — $ 4,351 $ 4,351 Fair Value (in thousands) Measured as of Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 25,654 $ — $ — $ 25,654 Commercial paper — 950 — 950 Total cash equivalents $ 25,654 $ 950 $ — $ 26,604 Marketable investments: U.S. treasury securities $ 161,465 $ — $ — $ 161,465 U.S. agency and government sponsored securities — 4,970 — 4,970 Commercial paper — 39,834 — 39,834 Corporate bonds — 165,190 — 165,190 Asset-backed securities — 46,466 — 46,466 Marketable equity investments 44,216 — — 44,216 Total marketable investments $ 205,681 $ 256,460 $ — $ 462,141 Liabilities: Private Warrants — — 31,230 31,230 Total warrant liabilities $ — $ — $ 31,230 $ 31,230

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted loss per share for the three and six months ended June 30, 2022 and 2021 (in thousands, except for share and per share amounts): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Numerator: Net loss $ (95,239) $ (36,830) $ (183,572) $ (112,753) Denominator: Weighted average common shares outstanding—Basic 352,054,529 340,255,023 350,378,494 336,641,349 Weighted average common shares outstanding—Diluted 352,054,529 340,255,023 350,378,494 336,641,349 Net loss per share attributable to common shareholders—Basic and Diluted $ (0.27) $ (0.11) $ (0.52) $ (0.33)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table presents the potential shares of Common Stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: June 30, 2022 Warrants 5,757,549 Stock-based awards—Equity classified 41,876,648 Stock-based awards—Liability classified 12,563,535 Vendor stock-in-lieu of cash program 969,224 Convertible Senior Notes 31,279,716 Earn-out shares 8,606,717 Total 101,053,389

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Vendor Stock-in-lieu of Cash Program	The Company’s vendor Stock-in-lieu of Cash Program activity for the six months ended June 30, 2022 was as follows: Shares Weighted Average Unvested shares as of December 31, 2021 1,500,000 $ 15.72 Granted 8,286,665 10.05 Vested (4,926,990) 11.06 Unvested shares as of June 30, 2022 4,859,675 10.60

Stock-based Compensation (Table

Stock-based Compensation (Tables)	6 Months Ended
	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	A summary of the Company’s stock option activity for the six months ended June 30, 2022 was as follows: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2021 11,507,643 $ 1.72 Exercised (1,053,499) 1.67 Cancelled/Forfeited (826,089) 1.67 Outstanding as of June 30, 2022 9,628,055 1.73 7.23 $ 41,035
Schedule of Restricted Stock Awards Activity	Restricted stock awards activity for the six months ended June 30, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 666,298 $ 1.21 Forfeited (17,429) 1.23 Vested (309,888) 1.18 Outstanding as of June 30, 2022 338,981 1.23 A summary of the Company’s restricted stock units activity for the six months ended June 30, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 11,983,032 $ 19.56 Granted 9,974,655 12.84 Forfeited (794,702) 18.14 Vested (3,276,558) 17.73 Outstanding as of June 30, 2022 17,886,427 16.20
Schedule of Stock-based Compensation Expense by Function	Stock-based compensation expense by function was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of sales $ 6,989 $ 1,127 $ 8,775 $ 1,210 Research and development 8,714 5,663 15,816 6,425 Sales and marketing 2,741 934 5,609 1,120 General and administrative 20,181 6,806 35,123 7,612 Total $ 38,625 $ 14,530 $ 65,323 $ 16,367 Stock-based compensation expense by type of award was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Equity Classified Awards: Stock options $ 748 $ 1,235 $ 1,270 $ 1,398 RSAs 187 250 21 1,924 RSUs 32,540 12,426 54,049 12,426 ESPP 157 — 157 — Liability Classified Awards: Fixed value equity awards 1,741 619 3,521 619 Optogration awards 394 — 3,447 — Freedom Photonics awards 2,800 — 2,800 — Solfice awards 58 — 58 — Total $ 38,625 $ 14,530 $ 65,323 $ 16,367

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2022
Leases [Abstract]
Schedule of Components of Lease Expenses, Supplemental Cash Flow Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates	The components of lease expenses for were as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Operating lease cost $ 1,597 $ 1,184 $ 2,713 $ 2,358 Variable lease cost 515 445 1,070 904 Total operating lease cost $ 2,112 $ 1,629 $ 3,783 $ 3,262 Supplemental cash flow information related to leases was as follows (in thousands): Six Months Ended June 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (2,857) $ (2,459) Right of use assets obtained in exchange for lease obligations: Operating leases 9,993 2,876 Weighted average remaining terms were as follows (in years): June 30, 2022 December 31, 2021 Weighted average remaining lease term Operating leases 4.21 2.95 Weighted average discount rates were as follows: June 30, 2022 December 31, 2021 Weighted average discount rate Operating leases 4.23 % 2.80 %
Schedule of Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases was as follows (in thousands): June 30, 2022 December 31, 2021 Operating leases: Operating lease right-of-use assets $ 17,447 $ 9,145 Operating lease liabilities: Operating lease liabilities, current $ 6,217 $ 4,735 Operating lease liabilities, non-current 12,464 5,768 Total operating lease liabilities $ 18,681 $ 10,503
Schedule of Maturities of Lease Liabilities	Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2022 (remaining six months) $ 3,213 2023 5,758 2024 3,298 2025 3,304 2026 2,777 2027 1,903 Thereafter 799 Total lease payments 21,052 Less: imputed interest (2,371) Total leases liabilities $ 18,681

Segment and Customer Concentr_2

Segment and Customer Concentration Information (Tables)	6 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Schedule of Segment Operating Results and Reconciliations to the Consolidated Balances	The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands): Three Months Ended June 30, 2022 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 4,179 $ 5,753 $ 9,932 $ — $ 9,932 Revenues from internal customer 5,435 504 5,939 (5,939) — Total revenue $ 9,614 $ 6,257 $ 15,871 $ (5,939) $ 9,932 Depreciation and amortization $ 976 $ 763 $ 1,739 $ — $ 1,739 Operating income (loss) (105,592) 728 (104,864) 424 (104,440) Other significant items: Segment assets 786,708 51,046 837,754 (62,157) 775,597 Inventories, net 9,022 327 9,349 — 9,349 Three Months Ended June 30, 2021 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 5,822 $ 487 $ 6,309 $ — $ 6,309 Revenues from internal customer 1,846 1,207 3,053 (3,053) — Total revenue $ 7,668 $ 1,694 $ 9,362 $ (3,053) $ 6,309 Depreciation and amortization $ 652 $ 23 $ 675 $ — $ 675 Operating income (loss) (44,169) (76) (44,245) 44 (44,201) Other significant items: Segment assets 625,386 3,483 628,869 (2,702) 626,167 Inventories, net 4,288 30 4,318 — 4,318 Six Months Ended June 30, 2022 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 10,077 $ 6,710 $ 16,787 $ — $ 16,787 Revenues from internal customer 7,796 2,660 10,456 (10,456) — Total revenue $ 17,873 $ 9,370 $ 27,243 $ (10,456) $ 16,787 Depreciation and amortization $ 1,520 $ 1,024 $ 2,544 $ — $ 2,544 Operating loss (187,769) 998 (186,771) — (186,771) Other significant items: Segment assets 786,708 51,046 837,754 (62,157) 775,597 Inventories, net 9,022 327 9,349 — 9,349 Six Months Ended June 30, 2021 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 10,158 $ 1,464 $ 11,622 $ — $ 11,622 Revenues from internal customer 3,121 2,349 5,470 (5,470) — Total revenue $ 13,279 $ 3,813 $ 17,092 $ (5,470) $ 11,622 Depreciation and amortization $ 1,290 $ 43 $ 1,333 $ (1) $ 1,332 Operating income (loss) (73,037) (313) (73,350) (95) (73,445) Other significant items: Segment assets 625,386 3,483 628,869 (2,702) 626,167 Inventories, net 4,288 30 4,318 — 4,318 (1) Represents the eliminations of all intercompany balances and transactions during the period presented.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details)	6 Months Ended
	Jun. 30, 2022 operatingSegment
Accounting Policies [Abstract]
Number of operating segments	2

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) - Accounts Receivable - Customer Concentration Risk	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Customer One
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	17%	39%
Customer Two
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	13%	31%

Business Combination - Narrativ

Business Combination - Narrative (Details) - Freedom Photonics $ in Millions	Apr. 13, 2022 USD ($)
Business Acquisition [Line Items]
Stock consideration	$ 34.2
Merger related expenses incurred	$ 1.4

Business Combination - Schedule

Business Combination - Schedule of Recognized Identified Assets and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Apr. 13, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill	$ 18,465		$ 3,110
Freedom Photonics
Business Acquisition [Line Items]
Cash and cash equivalents		$ 1,063
Accounts receivable		3,235
Contract asset		1,913
Inventories, net		127
Prepaid expenses and other current assets		70
Property and equipment		1,353
Operating lease right-of-use assets		449
Other non-current assets		22
Intangible assets		15,600
Goodwill		15,520
Total assets acquired		39,352
Current Liabilities		(4,036)
Non-current liabilities		(1,135)
Total liabilities assumed		(5,171)
Net assets acquired		$ 34,181

Business Combination - Componen

Business Combination - Components of Intangible Assets and Estimated Useful Lives (Details) - USD ($) $ in Thousands		6 Months Ended	12 Months Ended
	Apr. 13, 2022	Jun. 30, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)		7 years	9 years 7 months 6 days
Preliminary Recorded Value		$ 24,540	$ 2,650
Customer backlog
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)		1 year 4 months 24 days
Preliminary Recorded Value		$ 650	$ 0
Customer relationships
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)		4 years 4 months 24 days	9 years 7 months 6 days
Preliminary Recorded Value		$ 3,730	$ 780
Developed technology
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)		8 years	9 years 7 months 6 days
Preliminary Recorded Value		$ 11,910	$ 1,750
In-process research and development (IPR&D)
Business Acquisition [Line Items]
Preliminary Recorded Value		$ 7,500	0
Tradename
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)		3 years 9 months 18 days
Preliminary Recorded Value		$ 620	$ 120
Freedom Photonics
Business Acquisition [Line Items]
Total intangible assets	$ 15,600
Freedom Photonics | Customer backlog
Business Acquisition [Line Items]
Preliminary Recorded Value	$ 650
Freedom Photonics | Customer backlog | Maximum
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)	2 years
Freedom Photonics | Customer relationships
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)	4 years
Preliminary Recorded Value	$ 2,950
Freedom Photonics | Developed technology
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)	8 years
Preliminary Recorded Value	$ 4,000
Freedom Photonics | In-process research and development (IPR&D)
Business Acquisition [Line Items]
Preliminary Recorded Value	$ 7,500
Freedom Photonics | Tradename
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)	4 years
Preliminary Recorded Value	$ 500

Business Combinations - Impact

Business Combinations - Impact of Adjustments to the Unaudited Pro Forma (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2021
Acquisition-related Costs
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Net loss	$ (417)	$ 0	$ (2,582)	$ 2,795
Transaction costs					$ 2,800
Stock Based Compensation Costs
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Net loss	$ 525	$ 4,271	$ 4,159	$ 11,277

Business Combinations - Unaudit

Business Combinations - Unaudited Pro Forma (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Business Combination and Asset Acquisition [Abstract]
Revenue	$ 10,481	$ 11,385	$ 22,511	$ 21,534
Net loss	$ (95,470)	$ (40,823)	$ (185,410)	$ (126,631)

Revenue - Schedule of Disaggreg

Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 9,932	$ 6,309	$ 16,787	$ 11,622
Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%	100%	100%
Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%	100%	100%
Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%	100%	100%
Autonomy Solutions
Disaggregation of Revenue [Line Items]
Revenue	$ 4,179	$ 5,822	$ 10,077	$ 10,158
Autonomy Solutions | Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	42%	92%	60%	87%
ATS
Disaggregation of Revenue [Line Items]
Revenue	$ 5,753	$ 487	$ 6,710	$ 1,464
ATS | Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	58%	8%	40%	13%
Recognized at a point in time
Disaggregation of Revenue [Line Items]
Revenue	$ 1,798	$ 1,988	$ 3,339	$ 4,041
Recognized at a point in time | Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	18%	32%	20%	35%
Recognized over time
Disaggregation of Revenue [Line Items]
Revenue	$ 8,134	$ 4,321	$ 13,448	$ 7,581
Recognized over time | Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	82%	68%	80%	65%
North America
Disaggregation of Revenue [Line Items]
Revenue	$ 8,716	$ 4,061	$ 13,684	$ 6,600
North America | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	88%	65%	81%	57%
Asia Pacific
Disaggregation of Revenue [Line Items]
Revenue	$ 932	$ 154	$ 2,792	$ 475
Asia Pacific | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	9%	2%	17%	4%
Europe and Middle East
Disaggregation of Revenue [Line Items]
Revenue	$ 284	$ 2,094	$ 311	$ 4,547
Europe and Middle East | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	3%	33%	2%	39%

Revenue - Narrative (Details)

Revenue - Narrative (Details) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Mar. 31, 2020 USD ($) tranche $ / shares shares
Class of Warrant or Right [Line Items]
Fair value of warrants outstanding	$ 4,351		$ 4,351		$ 31,230
Change in fair value of warrant liabilities	11,733	$ 6,928	7,876	$ (39,721)
Contract assets	18,297		18,297		9,907	$ 0
Contract liabilities	$ 3,665		$ 3,665		898
VCTF warrant
Class of Warrant or Right [Line Items]
Number of tranches | tranche							2
Fair value of warrants outstanding							$ 2,900
Change in fair value of warrant liabilities					$ 1,000
Class A Common Stock | VCTF warrant
Class of Warrant or Right [Line Items]
Conversion of warrants into securities (in shares) | shares							4,089,280
Stock price of warrants (in dollars per share) | $ / shares							$ 3.1769

Revenue - Schedule of Significa

Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Contract With Customer Asset [Roll Forward]
Beginning balance	$ 9,907	$ 0
Amounts billed that were included in the contract assets beginning balance	(1,602)
Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed	9,992	9,907
Ending balance	18,297	9,907
Contract with Customer, Liability [Roll Forward]
Beginning balance	898	2,284
Revenue recognized that was included in the contract liabilities beginning balance	(397)	(1,792)
Net increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period	3,197	406
Ending balance	$ 3,698	$ 898

Revenue - Schedule of Opening a

Revenue - Schedule of Opening and Closing Balances of Contract Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Contract liabilities, current	$ 3,665	$ 898
Contract liabilities, non-current	33	0
Contract with customer, liability, total	$ 3,698	$ 898	$ 2,284

Investments - Amortized Cost (D

Investments - Amortized Cost (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Cost	$ 507,932	$ 419,783
Gross Unrealized Gains	0	14
Gross Unrealized Losses	(6,005)	(922)
Fair Value	501,927	418,875
Included in cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Cost	7,499	950
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1)	0
Fair Value	7,498	950
Included in marketable securities
Debt Securities, Available-for-sale [Line Items]
Cost	500,433	418,833
Gross Unrealized Gains	0	14
Gross Unrealized Losses	(6,004)	(922)
Fair Value	494,429	417,925
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Cost	241,313	161,938
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(3,556)	(474)
Fair Value	237,757	161,465
U.S. agency and government sponsored securities
Debt Securities, Available-for-sale [Line Items]
Cost	4,997	4,995
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(116)	(25)
Fair Value	4,881	4,970
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Cost	82,168	40,788
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(156)	(4)
Fair Value	82,012	40,784
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Cost	147,720	165,522
Gross Unrealized Gains	0	13
Gross Unrealized Losses	(1,838)	(345)
Fair Value	145,882	165,190
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Cost	31,734	46,540
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(339)	(74)
Fair Value	$ 31,395	$ 46,466

Investments - Continuous Loss P

Investments - Continuous Loss Position (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	$ (6,005)	$ (922)
Fair Value	501,927	372,482
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(3,556)	(474)
Fair Value	237,757	146,454
U.S. agency and government sponsored securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(116)	(25)
Fair Value	4,881	4,970
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(156)	(4)
Fair Value	82,012	30,285
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(1,838)	(345)
Fair Value	145,882	145,522
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(339)	(74)
Fair Value	$ 31,395	$ 45,251

Investments - Schedule of Equit

Investments - Schedule of Equity Investments (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	$ 72,228	$ 79,872
Money market funds | Cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	28,107	25,654
Marketable equity investments | Marketable securities
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	34,119	44,216
Non-marketable equity investment | Other non-current assets
Debt Securities, Available-for-sale [Line Items]
Non-marketable equity investment measured using the measurement alternative	$ 10,002	$ 10,002

Investments - Narrative (Detail

Investments - Narrative (Details) - Robotic Research OpCo, LLC - USD ($) $ in Millions	1 Months Ended	6 Months Ended
	Dec. 31, 2021	Jun. 30, 2022
Debt Securities, Available-for-sale [Line Items]
Investment in Robotic Research, percentage of capitalization (percent, less than)	5%
Class A Preferred Units
Debt Securities, Available-for-sale [Line Items]
Sale of stock (in shares)	1,495
Class A Common Stock
Debt Securities, Available-for-sale [Line Items]
Stock consideration	$ 10
Common stock, shares issued (in shares)		618,924

Financial Statement Component_2

Financial Statement Components - Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 41,112	$ 303,373
Money market funds	28,107	25,654
Commercial paper	7,498	950
Total cash and cash equivalents	$ 76,717	$ 329,977

Financial Statement Component_3

Financial Statement Components - Inventories, net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 2,900		$ 2,900		$ 5,866
Work-in-process	6,181		6,181		1,171
Finished goods	268		268		3,305
Total inventories, net	9,349	$ 4,318	9,349	$ 4,318	$ 10,342
Inventory write-downs	$ 3,400	$ 1,200	$ 4,778	$ 1,453

Financial Statement Component_4

Financial Statement Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses	$ 13,692	$ 14,651
Contract assets	18,297	9,907
Advance payments to vendors	11,188	1,810
Other receivables	3,001	2,827
Prepaid expenses and other current assets	$ 46,178	$ 29,195

Financial Statement Component_5

Financial Statement Components - Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 27,847		$ 27,847		$ 17,787
Accumulated depreciation and amortization	(7,901)		(7,901)		(6,778)
Total property and equipment, net	19,946		19,946		11,009
Depreciation and amortization	900	$ 700	1,700	$ 1,300
Machinery and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	10,000		10,000		7,694
Computer hardware and software
Property, Plant and Equipment [Line Items]
Total property and equipment	2,515		2,515		2,854
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	885		885		869
Vehicles, including demonstration fleet
Property, Plant and Equipment [Line Items]
Total property and equipment	2,473		2,473		2,421
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	850		850		272
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 11,124		$ 11,124		$ 3,677

Financial Statement Component_6

Financial Statement Components - Schedule of Intangible Assets (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Intangible Assets (Including Goodwill) [Roll Forward]
Beginning of the period			$ 2,424,000	$ 0	$ 0
Additions			21,890,000		2,650,000
Amortization	$ (800,000)	$ 0	(856,000)	$ 0	(226,000)
End of the period	23,458,000		23,458,000		2,424,000
Gross Carrying Amount	24,540,000		24,540,000		2,650,000
Accumulated Amortization	(1,082,000)		(1,082,000)		(226,000)
Net Carrying Amount	23,458,000		$ 23,458,000		$ 2,424,000
Weighted Average Remaining Period (Years)			7 years		9 years 7 months 6 days
Customer relationships
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	3,730,000		$ 3,730,000		$ 780,000
Accumulated Amortization	(256,000)		(256,000)		(33,000)
Net Carrying Amount	3,474,000		$ 3,474,000		$ 747,000
Weighted Average Remaining Period (Years)			4 years 4 months 24 days		9 years 7 months 6 days
Customer backlog
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	650,000		$ 650,000		$ 0
Accumulated Amortization	(98,000)		(98,000)		0
Net Carrying Amount	552,000		$ 552,000		0
Weighted Average Remaining Period (Years)			1 year 4 months 24 days
Tradename
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	620,000		$ 620,000		120,000
Accumulated Amortization	(151,000)		(151,000)		(120,000)
Net Carrying Amount	469,000		$ 469,000		0
Weighted Average Remaining Period (Years)			3 years 9 months 18 days
Assembled workforce
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	130,000		$ 130,000		0
Accumulated Amortization	(130,000)		(130,000)		0
Net Carrying Amount	0		0		0
Developed technology
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	11,910,000		11,910,000		1,750,000
Accumulated Amortization	(447,000)		(447,000)		(73,000)
Net Carrying Amount	11,463,000		$ 11,463,000		$ 1,677,000
Weighted Average Remaining Period (Years)			8 years		9 years 7 months 6 days
IPR&D
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	7,500,000		$ 7,500,000		$ 0
Accumulated Amortization	0		0		0
Net Carrying Amount	$ 7,500,000		$ 7,500,000		$ 0

Financial Statement Component_7

Financial Statement Components - Future Amortization Expense (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
2022 (remaining six months)	$ 1,381,000		$ 1,381,000
2023	2,730,000		2,730,000
2024	2,373,000		2,373,000
2025	2,373,000		2,373,000
2026	1,726,000		1,726,000
Thereafter	5,375,000		5,375,000
IPR&D	7,500,000		7,500,000
Net Carrying Amount	23,458,000		23,458,000		$ 2,424,000
Amortization	$ 800,000	$ 0	$ 856,000	$ 0	$ 226,000

Financial Statement Component_8

Financial Statement Components - Goodwill (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Goodwill [Line Items]
Balance as of December 31, 2021	$ 3,110
Balance as of June 30, 2022	18,465
Optogration
Goodwill [Line Items]
Adjustment to goodwill related to Optogration acquisition in 2021	(165)
Freedom Photonics
Goodwill [Line Items]
Acquired goodwill related to Freedom Photonics in 2022	15,520
Autonomy Solutions
Goodwill [Line Items]
Balance as of December 31, 2021	687
Balance as of June 30, 2022	687
Autonomy Solutions | Optogration
Goodwill [Line Items]
Adjustment to goodwill related to Optogration acquisition in 2021	0
Autonomy Solutions | Freedom Photonics
Goodwill [Line Items]
Acquired goodwill related to Freedom Photonics in 2022	0
ATS
Goodwill [Line Items]
Balance as of December 31, 2021	2,423
Balance as of June 30, 2022	17,778
ATS | Optogration
Goodwill [Line Items]
Adjustment to goodwill related to Optogration acquisition in 2021	(165)
ATS | Freedom Photonics
Goodwill [Line Items]
Acquired goodwill related to Freedom Photonics in 2022	$ 15,520

Financial Statement Component_9

Financial Statement Components - Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Security deposits	$ 2,333	$ 1,187
Non-marketable equity investment	10,002	10,002
Advance payment for capital projects	11,966	0
Other non-current assets	929	1,266
Other non-current assets	$ 25,230	$ 12,455

Financial Statement Componen_10

Financial Statement Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation and benefits	$ 16,180	$ 9,899
Accrued expenses	7,267	6,727
Warranty reserves	549	1,798
Contract liabilities	3,665	898
Accrued interest payable	327	316
Contract losses	3,492	115
Other	24	91
Accrued and other current liabilities	$ 31,504	$ 19,844

Convertible Senior Notes and _3

Convertible Senior Notes and Capped Call Transactions - Narrative (Details)	1 Months Ended					3 Months Ended	6 Months Ended
	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2021 USD ($) trading_day $ / shares	Dec. 31, 2021 USD ($) consecutive_trading_day $ / shares	Dec. 31, 2021 USD ($) consecutive_business_day $ / shares	Jun. 30, 2022 USD ($) $ / shares	Jun. 30, 2022 USD ($) $ / shares shares
Debt Instrument [Line Items]
Accrued interest repaid						$ 1,900,000	$ 3,900,000
Stock option, capped calls, initial strike price (in dollars per share) | $ / shares	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98
Stock option, capped calls, initial cap price (in dollars per share) | $ / shares	$ 30.16	$ 30.16	$ 30.16	$ 30.16	$ 30.16
Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares						$ 0.0001	$ 0.0001
Convertible Senior Notes Due 2026 | Convertible Debt
Debt Instrument [Line Items]
Principal	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000
Interest rate (as a percent)	1.25%	1.25%	1.25%	1.25%	1.25%
Proceeds from the issuance of debt		$ 75,000,000
Proceeds from convertible debt		$ 609,400,000
Debt instrument, convertible, shares issuable | shares							50.0475
Conversion price (in dollars per share) | $ / shares	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98
Debt issuance costs, net	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000
Note term (in months)							4 years 5 months 19 days
Payments to purchase capped calls							$ 73,400,000
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days | trading_day			20
Debt instrument, convertible, threshold consecutive trading days | consecutive_trading_day				30
Debt instrument, redemption price, percentage	100%
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Debt instrument, convertible, threshold percentage of stock price trigger	130%
Debt instrument, convertible, threshold trading days | trading_day			20
Debt instrument, convertible, threshold consecutive trading days | consecutive_trading_day				30
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days				10	5
Debt instrument, convertible, threshold percent of conversion price triggering convertible feature	98%
Convertible Senior Notes Due 2026 | Convertible Debt | Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Convertible Senior Notes Due 2026 | Convertible Debt | Class A Common Stock | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, convertible, threshold percentage of stock price trigger	130%

Convertible Senior Notes and _4

Convertible Senior Notes and Capped Call Transactions - Schedule of Net Carrying Amount (Details) - Convertible Senior Notes Due 2026 - Convertible Debt - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Principal	$ 625,000,000	$ 625,000,000
Unamortized debt discount and issuance costs	(14,425,000)	(16,043,000)
Net carrying amount	$ 610,575,000	$ 608,957,000

Convertible Senior Notes and _5

Convertible Senior Notes and Capped Call Transactions - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Debt Instrument [Line Items]
Interest expense and other	$ 3,148	$ 288	$ 6,428	$ 488
Convertible Senior Notes Due 2026 | Convertible Debt
Debt Instrument [Line Items]
Contractual interest expense	1,948		3,874
Amortization of premium on marketable securities	809		1,618
Interest expense and other	$ 2,757		$ 5,492

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) $ in Millions	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Level 3 | Expected Term | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants term (in years)	3 years 5 months 4 days
Level 3 | Price Volatility | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	0.842
Level 3 | Risk-Free Interest Rate | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	0.0299
Level 2
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible senior notes, fair value	$ 353.8	$ 669.4

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details) - Warrants - Private Warrants $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ 31,230
Change in fair value prior to exercises	4,713
Reduction in liability due to exercises	(19,003)
Change in fair value of outstanding warrants	(12,589)
Balance at end of period	$ 4,351

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Assets:
Marketable investments:	$ 501,927	$ 418,875
Liabilities:
Warrant liabilities	4,351	31,230
U.S. treasury securities
Assets:
Marketable investments:	237,757	161,465
U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,881	4,970
Corporate bonds
Assets:
Marketable investments:	145,882	165,190
Asset-backed securities
Assets:
Marketable investments:	31,395	46,466
Fair Value, Recurring
Assets:
Total cash equivalents	35,605	26,604
Equity investments	34,119	44,216
Total marketable investments	528,548	462,141
Liabilities:
Warrant liabilities	4,351	31,230
Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	4,351	31,230
Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	237,757	161,465
Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,881	4,970
Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	74,514	39,834
Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	145,882	165,190
Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	31,395	46,466
Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	28,107	25,654
Fair Value, Recurring | Commercial paper
Assets:
Total cash equivalents	7,498	950
Level 1 | Fair Value, Recurring
Assets:
Total cash equivalents	28,107	25,654
Equity investments	34,119	44,216
Total marketable investments	271,876	205,681
Liabilities:
Warrant liabilities	0	0
Level 1 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	0	0
Level 1 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	237,757	161,465
Level 1 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	28,107	25,654
Level 1 | Fair Value, Recurring | Commercial paper
Assets:
Total cash equivalents	0	0
Level 2 | Fair Value, Recurring
Assets:
Total cash equivalents	7,498	950
Equity investments	0	0
Total marketable investments	256,672	256,460
Liabilities:
Warrant liabilities	0	0
Level 2 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	0	0
Level 2 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	0	0
Level 2 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,881	4,970
Level 2 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	74,514	39,834
Level 2 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	145,882	165,190
Level 2 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	31,395	46,466
Level 2 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	0	0
Level 2 | Fair Value, Recurring | Commercial paper
Assets:
Total cash equivalents	7,498	950
Level 3 | Fair Value, Recurring
Assets:
Total cash equivalents	0	0
Equity investments	0	0
Total marketable investments	0	0
Liabilities:
Warrant liabilities	4,351	31,230
Level 3 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	4,351	31,230
Level 3 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	0	0
Level 3 | Fair Value, Recurring | Commercial paper
Assets:
Total cash equivalents	$ 0	$ 0

Earnings (Loss) Per Share - Bas

Earnings (Loss) Per Share - Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator:
Net loss	$ (95,239)	$ (36,830)	$ (183,572)	$ (112,753)
Denominator:
Weighted average common shares outstanding- Basic (in shares)	352,054,529	340,255,023	350,378,494	336,641,349
Weighted average common shares outstanding- Diluted (in shares)	352,054,529	340,255,023	350,378,494	336,641,349
Net loss per share attributable to common shareholders- Basic (in dollars per share)	$ (0.27)	$ (0.11)	$ (0.52)	$ (0.33)
Net loss per share attributable to common shareholders- Diluted (in dollars per share)	$ (0.27)	$ (0.11)	$ (0.52)	$ (0.33)

Earnings (Loss) Per Share - Ant

Earnings (Loss) Per Share - Antidilutive Securities (Details)	6 Months Ended
	Jun. 30, 2022 shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	101,053,389
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	5,757,549
Stock-based awards—Equity classified
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	41,876,648
Stock-based awards—Liability classified
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	12,563,535
Vendor stock-in-lieu of cash program
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	969,224
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	31,279,716
Earn-out shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	8,606,717

Earnings (Loss) Per Share - Nar

Earnings (Loss) Per Share - Narrative (Details)	Jun. 30, 2022 $ / shares
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion price (in dollars per share)	$ 19.981

Stockholders' Equity (Details)

Stockholders' Equity (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended
	Apr. 30, 2022 shares	Jan. 31, 2022 shares	Jun. 30, 2022 USD ($) vote $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) vote $ / shares shares	Jun. 30, 2021 USD ($)	Dec. 31, 2021 shares
Class of Stock [Line Items]
Vendor payments in shares in lieu of cash (in shares)			7,612,315		8,286,665
Vendor payments in stock in lieu of cash, liability | $			$ 27,600		$ 27,600
Compensation expense | $			38,625	$ 14,530	65,323	$ 16,367
Research and development
Class of Stock [Line Items]
Compensation expense | $			8,714	$ 5,663	15,816	$ 6,425
Daimler North America Corporation
Class of Stock [Line Items]
Prepaid expenses and other current assets related to stock-in-lieu of cash program | $			7,200		7,200
Daimler North America Corporation | Research and development
Class of Stock [Line Items]
Compensation expense | $			$ 1,900		$ 3,900
Public Warrants
Class of Stock [Line Items]
Warrants outstanding (in shares)							0
Private Warrants
Class of Stock [Line Items]
Warrants outstanding (in shares)			1,668,269		1,668,269		3,077,021
Warrants exercised (in shares)	19,223	1,389,529
Shares issued for exercise of warrants (in shares)	4,387	401,365
Share per warrant (in shares)			1		1
Stock price of warrants (in dollars per share) | $ / shares			$ 11.50		$ 11.50
Class A Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)			715,000,000		715,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001
Common stock, shares issued (in shares)			282,211,653		282,211,653
Common stock, shares outstanding (in shares)			260,348,203		260,348,203
Common stock, votes per share | vote			1		1
Class A Common Stock | Daimler North America Corporation
Class of Stock [Line Items]
Vendor payments in shares in lieu of cash (in shares)					1,500,000
Award vesting period (in years and in months)					2 years
Shares issued in period (in shares)					750,000
Class B Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)			121,000,000		121,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001
Common stock, shares issued (in shares)			97,088,670		97,088,670
Common stock, shares outstanding (in shares)			97,088,670		97,088,670
Common stock, votes per share | vote			10		10

Stockholders' Equity - Stock-in

Stockholders' Equity - Stock-in-lieu of Cash Program Activity (Details)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Shares
Outstanding at beginning of period (in shares) | shares	11,507,643
Outstanding at end of period (in shares) | shares	9,628,055
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 1.72
Outstanding at end of period (in dollars per share) | $ / shares	$ 1.73
Vendor stock-in-lieu of cash program
Shares
Outstanding at beginning of period (in shares) | shares	1,500,000
Granted (in shares) | shares	8,286,665
Vested (in shares) | shares	(4,926,990)
Outstanding at end of period (in shares) | shares	4,859,675
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 15.72
Granted (in dollars per share) | $ / shares	10.05
Vested (in dollars per share) | $ / shares	11.06
Outstanding at end of period (in dollars per share) | $ / shares	$ 10.60

Stock-based Compensation - Narr

Stock-based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

6 Months Ended

11 Months Ended

36 Months Ended

May 02, 2022 USD ($) trading_day $ / shares shares

Jun. 30, 2022 USD ($) shares

Apr. 30, 2022 USD ($)

Aug. 31, 2021 USD ($)

Dec. 31, 2020 shares

Jun. 30, 2022 USD ($) shares

Jun. 30, 2021 USD ($)

Jun. 30, 2022 USD ($) shares

Jun. 30, 2021 USD ($)

Jun. 30, 2019

Jun. 30, 2022 USD ($) shares

Jun. 30, 2022 shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Intrinsic value of stock options exercised

$ 11,800

Fair value of options vested

1,500

Stock-based compensation expense

$ 38,625

$ 14,530

65,323

$ 16,367

Optogration Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-based compensation expense

$ 9,200

Contingent stock consideration

$ 22,000

Freedom Photonics Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-based compensation expense

2,800

Contingent stock consideration

$ 28,300

Solfice awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-based compensation expense

$ 100

Contingent stock consideration

$ 700

Employee Stock Purchase Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares authorized for issuance (in shares) | shares

7,317,655

Percentage of purchase price of shares

85%

Length of offering period

6 months

Shares of common stock in each purchase period (in shares) | shares

5,000

Class A Common Stock | Employee Stock Purchase Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Percentage of pre-tax earnings

15%

2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares authorized for issuance (in shares) | shares

36,588,278

36,588,278

36,588,278

36,588,278

36,588,278

Amended 2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Additional shares authorized for issuance (in shares) | shares

36,000,000

Percentage of outstanding stock maximum

5%

Incremental number of shares authorized (in shares) | shares

40,000,000

Stock-based awards—Equity classified | 2015 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Award expiration period (in years)

10 years

Stock-based awards—Equity classified | Tranche One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

1 year

Stock-based awards—Equity classified | Tranche One | 2015 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

Stock-based awards—Equity classified | Tranche Two | 2015 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

36 months

Award vesting percentage

75%

Stock-based awards—Liability classified | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Granted (in shares) | shares

0

Stock-based awards—Liability classified | Share-based Payment Arrangement, Employee | Tranche One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

1 year

Award vesting percentage

25%

Stock-based awards—Liability classified | Share-based Payment Arrangement, Employee | Tranche Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

36 months

Award vesting percentage

75%

Fixed value equity awards | Share-based Payment Arrangement, Employee | 2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Stock-based compensation expense

$ 1,700

$ 600

$ 3,500

$ 600

Fixed value equity awards | Share-based Payment Arrangement, Employee | Tranche One | 2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

Fixed value equity awards | Share-based Payment Arrangement, Employee | Tranche Two | 2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

Fixed value equity awards | Share-based Payment Arrangement, Employee | Tranche Three | 2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

Fixed value equity awards | Share-based Payment Arrangement, Employee | Tranche Four | 2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

RSUs | Chief Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

10,800,000

Stock-based compensation expense

$ 3,500

Grant date fair value (in dollars per share) | $ / shares

$ 12.61

Consecutive trading days | trading_day

90

Service period (in years)

7 years

RSUs | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

6 years

RSUs | Achievement of $50 stock price | Chief Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

$ 50

RSUs | Achievement of $60 stock price | Chief Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

60

RSUs | Achievement of $70 stock price | Chief Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

$ 70

RSUs | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

9,974,655

Stock-based Compensation - Stoc

Stock-based Compensation - Stock Option Activity (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares
Number of Common Stock Options
Outstanding at beginning of period (in shares) | shares	11,507,643
Exercised (in shares) | shares	(1,053,499)
Forfeited (in shares) | shares	(826,089)
Outstanding at end of period (in shares) | shares	9,628,055
Weighted- Average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 1.72
Exercised (in dollars per share) | $ / shares	1.67
Forfeited (in dollars per share) | $ / shares	1.67
Outstanding at end of period (in dollars per share) | $ / shares	$ 1.73
Weighted- Average Remaining Contractual Life (Years)
Outstanding balance	7 years 2 months 23 days
Aggregate Intrinsic Value (In Thousands)
Outstanding balance | $	$ 41,035

Stock-based Compensation - Rest

Stock-based Compensation - Restricted Stock Activity (Details)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Stock-based awards—Liability classified
Shares
Outstanding at beginning of period (in shares) | shares	666,298
Forfeited (in shares) | shares	(17,429)
Vested (in shares) | shares	(309,888)
Outstanding at end of period (in shares) | shares	338,981
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share)	$ 1.21
Forfeited (in dollars per share)	1.23
Vested (in dollars per share)	1.18
Outstanding at end of period (in dollars per share)	$ 1.23
RSUs
Shares
Outstanding at beginning of period (in shares) | shares	11,983,032
Forfeited (in shares) | shares	(794,702)
Vested (in shares) | shares	(3,276,558)
Outstanding at end of period (in shares) | shares	17,886,427
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share)	$ 19.56
Granted (in dollars per share)	12.84
Forfeited (in dollars per share)	18.14
Vested (in dollars per share)	17.73
Outstanding at end of period (in dollars per share)	$ 16.20

Stock-based Compensation - Comp

Stock-based Compensation - Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 38,625	$ 14,530	$ 65,323	$ 16,367
Fixed value equity awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	1,741	619	3,521	619
Optogration awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	394	0	3,447	0
Freedom Photonics awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	2,800	0	2,800	0
Solfice awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	58	0	58	0
Stock-based awards—Equity classified
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	748	1,235	1,270	1,398
RSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	187	250	21	1,924
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	32,540	12,426	54,049	12,426
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	157	0	157	0
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	6,989	1,127	8,775	1,210
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	8,714	5,663	15,816	6,425
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	2,741	934	5,609	1,120
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 20,181	$ 6,806	$ 35,123	$ 7,612

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ (13)	$ 0	$ 391	$ 0
Effective tax rate, percent			0.20%	0%

Leases - Narrative (Details)

Leases - Narrative (Details) - renewalOption	6 Months Ended
	Jun. 30, 2022	Oct. 31, 2021
Lessee, Lease, Description [Line Items]
Term of lease (in moths)		65 months
Minimum
Lessee, Lease, Description [Line Items]
Number of renewal options	1
Renewal lease term (in years)	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal lease term (in years)	6 years

Leases - Components of Lease Ex

Leases - Components of Lease Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Leases [Abstract]
Operating lease cost	$ 1,597	$ 1,184	$ 2,713	$ 2,358
Variable lease cost	515	445	1,070	904
Total operating lease cost	$ 2,112	$ 1,629	$ 3,783	$ 3,262

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases included in operating activities	$ (2,857)	$ (2,459)
Right of use assets obtained in exchange for lease obligations:
Operating leases	$ 9,993	$ 2,876

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Operating leases:
Operating lease right-of-use assets	$ 17,447	$ 9,145
Operating lease liabilities, current	6,217	4,735
Operating lease liabilities, non-current	12,464	5,768
Total operating lease liabilities	$ 18,681	$ 10,503
Weighted average remaining lease term
Operating leases (in years)	4 years 2 months 15 days	2 years 11 months 12 days
Weighted average discount rate
Operating leases (as a percent)	4.23%	2.80%

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Operating Leases
2022 (remaining six months)	$ 3,213
2023	5,758
2024	3,298
2025	3,304
2026	2,777
2027	1,903
Thereafter	799
Total lease payments	21,052
Less: imputed interest	(2,371)
Total leases liabilities	$ 18,681	$ 10,503

Commitment and Contingencies -

Commitment and Contingencies - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2022	May 31, 2022
Other Commitments [Line Items]
Purchase obligations		$ 62.3
P3 USA, Inc.
Other Commitments [Line Items]
Purchase commitment		$ 30
Class A Common Stock | ECARX Holdings Inc. | Chairman and Chief Executive Officer
Other Commitments [Line Items]
Purchase of ordinary shares (in shares)			1,500,000
Share price (in dollars per share)			$ 10
Aggregate Amount			$ 15
Class A Common Stock | P3 USA, Inc.
Other Commitments [Line Items]
Shares issued for services (in shares)	291,940

Segment and Customer Concentr_3

Segment and Customer Concentration Information - Segment Operating Results and Reconciliation to the Consolidated Balances (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Revenue:
Revenue	$ 9,932	$ 6,309	$ 16,787	$ 11,622
Depreciation and amortization	1,739	675	2,544	1,332
Operating income (loss)	(104,440)	(44,201)	(186,771)	(73,445)
Other significant items:
Segment assets	775,597	626,167	775,597	626,167	$ 883,536
Inventories, net	9,349	4,318	9,349	4,318	$ 10,342
Reportable Segments
Revenue:
Revenue	15,871	9,362	27,243	17,092
Depreciation and amortization	1,739	675	2,544	1,333
Operating income (loss)	(104,864)	(44,245)	(186,771)	(73,350)
Other significant items:
Segment assets	837,754	628,869	837,754	628,869
Inventories, net	9,349	4,318	9,349	4,318
Eliminations
Revenue:
Revenue	(5,939)	(3,053)	(10,456)	(5,470)
Depreciation and amortization	0	0	0	(1)
Operating income (loss)	424	44	0	(95)
Other significant items:
Segment assets	(62,157)	(2,702)	(62,157)	(2,702)
Inventories, net	0	0	0	0
Autonomy Solutions
Revenue:
Revenue	4,179	5,822	10,077	10,158
Autonomy Solutions | Reportable Segments
Revenue:
Revenue	9,614	7,668	17,873	13,279
Depreciation and amortization	976	652	1,520	1,290
Operating income (loss)	(105,592)	(44,169)	(187,769)	(73,037)
Other significant items:
Segment assets	786,708	625,386	786,708	625,386
Inventories, net	9,022	4,288	9,022	4,288
Autonomy Solutions | Eliminations
Revenue:
Revenue	(5,435)	(1,846)	(7,796)	(3,121)
ATS
Revenue:
Revenue	5,753	487	6,710	1,464
ATS | Reportable Segments
Revenue:
Revenue	6,257	1,694	9,370	3,813
Depreciation and amortization	763	23	1,024	43
Operating income (loss)	728	(76)	998	(313)
Other significant items:
Segment assets	51,046	3,483	51,046	3,483
Inventories, net	327	30	327	30
ATS | Eliminations
Revenue:
Revenue	$ (504)	$ (1,207)	$ (2,660)	$ (2,349)

Segment and Customer Concentr_4

Segment and Customer Concentration Information - Narrative (Details) - Revenue from contract with customer benchmark - Customer Concentration Risk	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Customer One
Concentration Risk [Line Items]
Percentage of revenue (as percent)	24%	30%	35%	21%
Customer Two
Concentration Risk [Line Items]
Percentage of revenue (as percent)		30%	15%	37%
Customer Three
Concentration Risk [Line Items]
Percentage of revenue (as percent)		25%		18%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Jun. 30, 2022	Feb. 28, 2021
Mr. Heng
Related Party Transaction [Line Items]
Investment	$ 12.1		$ 15
Portion of investment sold	2.9
Investment, fair value	$ 12.2
Mr. Alec Gores
Related Party Transaction [Line Items]
Investment		$ 4.7